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Abstract 
Amyotrophic lateral sclerosis (ALS) is a fatal and progressive neurodegenerative disorder caused 
by the degeneration and death of motor neurons. While alterations in the metabolism of RNA, 
including RNA-binding proteins (RBPs) have been linked to the pathogenesis of ALS, our 
understanding of the role of non-coding RNAs including circular RNAs (circRNAs) is less well 
developed. In this study, using a combination of fluorescence in situ hybridization (FISH) and 
immunofluorescence (IF) with markers of RNP granules, I investigated the effect of osmotic 
stress on the localization and expression of a selection of circRNAs whose expression is 
dysregulated in ALS. Alteration in the number of granules for two circRNAs was observed in 
HEK293T cells under osmotic stress. I also have observed that circRNAs are present in 
ribonucleoprotein (RNP) granules under a stress condition. This finding is consistent with the 
hypothesis that circRNAs might participate in the biology of RNP granules under pathological 
conditions such as those observed in ALS. 
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Summary for Lay Audience 
There is a recently discovered group of RNAs which is circular and more stable than their linear 
counterparts. Evidence shows that these circular RNAs are abundant in the brain and can have a 
regulatory function at the cellular level. Some studies have suggested that circular RNAs 
(circRNAs) play a role in neurodegenerative diseases. Amyotrophic Lateral Sclerosis (ALS) is a 
progressive nervous system disease that is caused by loss of neurons controlling motor functions 
such as walking, grabbing, standing, reaching etc., and eventually results in death within 3 to 5 
years of diagnosis. It is shown that specific types of proteins that interact with RNA are 
aggregated in the neurons of ALS patients. There are also changes in the RNA expression in the 
spinal cord of ALS patients, supporting the idea of ALS as a disorder of altered RNA 
metabolism. RNA metabolism refers to different events occurring in the life cycle of RNAs such 
as, RNA synthesis, RNA processing and modification, RNA folding, and RNA degradation. 
Several studies also showed that there is a link between ALS pathogenesis and specific types of 
membraneless granular structures in the cells that are composed of RNAs and proteins. The 
formation of these granules can be affected by cellular stress which been said to play roles in 
ALS pathogenesis. In this study, I examined the effect of cellular stress on the expression and 
localization of circular RNAs for which the expression is altered in ALS.  I have found that 
cellular stress results in colocalization of candidate circRNA within those specific membraneless 
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Chapter 1  
1 Introduction and background 
1.1 Circular RNAs (circRNAs)  
1.1.1 NcRNAs 
Although the most well-studied sequences in the human genome are protein-coding genes, non-
protein-coding RNA occupies the majority of the human genome. The latest Human GENCODE 
Release 38 (GRCh38.p13), presented by the Encyclopedia of DNA Elements Consortium 
(ENCODE), showed that the human genome is composed of 60649 genes. Among those, 19955 
are protein-coding genes, whereas the remaining two-thirds of the genome represent noncoding 
RNA (ncRNA) genes (17944 long ncRNA genes, 7567 small ncRNA genes, and 14773 
pseudogenes) (Figure 1-1) (Genecode, 2021). 
In recent years, our understanding of the roles and functions of ncRNAs has dramatically 
increased, leading to a more comprehensive annotation of genomic locations and features of 
ncRNAs as well as to a better understanding of their function in various biological processes 
(Mattick & Makunin, 2006). Although there are different criteria considered for the classification 
of non-coding RNAs, in one classification, ncRNAs are classified as either housekeeping or 
regulatory ncRNAs. Housekeeping ncRNAs are constitutive expressing RNAs that are required 
for the maintenance of several key cellular processes. Ribosomal (rRNA), transfer (tRNA), small 
nuclear (snRNA), and small nucleolar RNAs (snoRNAs) are categorized in this group of 
ncRNAs. The other group is regulatory noncoding RNAs which are generally classified into two 
major classes: short ncRNAs (<200 nucleotides) and long ncRNAs (lncRNAs, >200 nucleotides) 
(Ponting et al, 2009; Sun & Kraus, 2015; Wilusz et al, 2009). Long ncRNAs could further be 
categorized into two types, linear ncRNAs and circular RNAs (circRNAs) (Figure 1-2) (Amodio 
et al, 2013; Costa, 2010). Table 1-1 provides more detail of the size and functions of ncRNAs. 
2 
2 
Figure 1-1: Schematic illustration of human genome presented by the Encyclopedia of DNA 






Figure 1-2:  Types of ncRNAs. Noncoding RNAs are categorized into housekeeping and 
regulatory noncoding RNAs. Housekeeping ncRNAs include rRNA, tRNA, snRNA, and 
snoRNAs. Regulatory noncoding RNAs include short ncRNAs or long ncRNAs. Long ncRNAs 
are including linear and circular RNAs (circRNAs).  
4 
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 Table 1-1: List of ncRNAs with their mean size and functions. 
  
Type Name Mean size Function 
Housekeeping 
ncRNAs 
Ribosomal RNA (rRNA) ~ 1.9 kb Protein synthesis 
(Dahlberg, 1989) 
Transfer RNA (tRNA) ~ 17 kb Protein synthesis 
(Nishimuka, 1972) 
Small nuclear RNA 
(snRNA) 
100-300 nt Involved in 
spliceosome complex 
(Karijolich & Yu, 2010) 
Small nucleolar RNA 
(snoRNA) 
60-300 nt Methylation and 
pseudo uridylation of 
other RNAs 
(Bachellerie et al, 
2002) 
Regulatory ncRNAs 
MicroRNA (miRNA) 18-21 nt regulation of gene 
expression (Huang et 
al, 2011) 
Small interfering RNAs 
(siRNAs) 








26-31 nt Regulation of 
chromatin state and 
transposon activity 
(Ernst et al, 2017; 
Yamanaka et al, 2014) 
long intergenic non-
coding RNAs (lincRNAs) 
≥ 200 nt Involved in large 
ribonucleoprotein 
complexes [1, 2] 
long intronic non-
coding RNAs 
≥ 200 nt Gene expression 
regulation (Heo & 
Sung, 2011; Louro et 
al, 2009; Tahira et al, 
2011) 




1.1.2 CircRNAs discovery and expression 
A less studied group of non-coding RNAs are circular RNAs (circRNAs) which have been 
shown to be evolutionarily conserved across mammals. To date, more than 140,000 human 
circRNA have been annotated according to CircBank data base (circbank). CircRNAs are long, 
noncoding endogenous RNA molecules with a covalently closed continuous loop without 5′–3′ 
polarity or a polyadenylated tail and which are largely concentrated in the nucleus. CircRNAs 
are generally formed by covalent binding of the 5′ site of an upstream exon with the 3′ of the 
same or a downstream exon (termed ‘back splicing’; discussed in detail later) (Jeck & Sharpless, 
2014).  
CircRNAs were first discovered in RNA viruses as viroids in early 1976 (Sanger et al, 1976). 
CircRNAs have now been observed in eukaryotic species although mostly at very low expression 
levels. Although initially considered as a by-product of spliceosome-mediated splicing errors, 
circRNAs are abundant in various cell lines and across different species (Chen & Yang, 2015). 
Advanced RNA sequencing (RNA-seq) and bioinformatics have revealed that there is a dynamic 
expression pattern of circRNAs in various physiological conditions and developmental stages (Li 
et al, 2015a; Li et al, 2015b; Zhu et al, 2017).  
1.1.3 Properties of circRNAs 
CircRNAs are distinguished by their covalently closed circular structures without a 5′ cap or a 3′ 
polyA tail. They are more stable than linear RNAs because of their circular structures, which 
makes them resistant to degradation by most RNA decay machinery. Most exonic circular RNAs 
exhibit a half-life of more than 48 hours, while an average half-life for mRNAs is 10 hours 
(Enuka et al, 2016; Jeck et al, 2013; Schwanhausser et al, 2013). CircRNAs (except for intron-
containing circRNA) are transported from the nucleus to the cytoplasm by an ATP- dependent 
mechanism. It has been also reported that transportation of long circRNAs from nucleus to the 
cytoplasm also requires helicase activity, so that the helicase depletion results in nuclear 
accumulation of long circRNAs (Huang et al, 2018). Nuclear retained circRNAs were found to 
be involved in transcriptional regulation (Jeck & Sharpless, 2014). They tend to have longer 
flanking introns (compared to non-circularized expressed exons) that are enriched with reverse 
complementary sequences, helping in their biogenesis. In some cases, circRNAs show higher 
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expression than their linear counterpart isoforms (Capel et al, 1993; Memczak et al, 2013; 
Salzman et al, 2013a; Sanger et al, 1976). CircRNAs exhibit cell and tissue type and 
developmental stage-specific expression (Salzman et al, 2013b). For instance, hsa-circRNA 2149 
is expressed in CD19+ leukocytes but cannot be detected in CD34+ leukocytes, neutrophils, or 
HEK293 cells. Several nematode circRNAs are expressed in oocytes but absent in 1- or 2-cell 
embryos (Memczak et al, 2013). 
1.1.4 Categories and biogenesis of circRNA 
Four groups of circRNAs have been identified which differ in their size, function and biogenesis.  
These include exonic circRNAs (ecircRNA) (single exon and multiple), exon-intron circRNAs 
(EIciRNA), circular intronic RNAs (ciRNA), and intergenic circRNAs (Lasda & Parker, 2014; 
Wang & Dong, 2019). Back-splicing ligates a downstream splice donor with an upstream splice 
acceptor, generating a covalently closed RNA transcript. This process is an additional type of 
alternative splicing that needs both cis-regulatory elements and trans-acting factors for the 
regulation of circRNA formation (Wang & Wang, 2015). CircRNAs use the same splicing 
machinery for their biogenesis as canonical alternative splicing; thus it is been said that circRNA 
production competes with pre-mRNA splicing (Ashwal-Fluss et al, 2014). While the precise 
details of the mechanism of circRNAs formation remained uncertain, three different models of 
circRNA biogenesis have been suggested. These include exon skipping or lariat-driven 
circularization, intron pairing-driven circularization (Ivanov et al, 2015; Jeck et al, 2013), and 
resplicing-driven circularization (Kameyama et al, 2012).  Each model is further discussed below 
(see also ). 
In the lariat-driven circularization model, the pre-mRNA partially folds during transcription 
which causes the 5′ splicing site of the upstream intron to approach and attack the 3′ splicing site 
of the downstream intron. When the middle exons are skipped during a linear alternative splicing 
event, the spliced-out intron lariat contains those skipped exons. This lariat precursor then can 
lead to the formation of circRNA when the lariat undergoes internal back-splicing (Eger et al, 
2018; Kelly et al, 2015; Kristensen et al, 2018a).  
Intron pairing-driven circularization is also known as the direct back-splicing mechanism. It has 
been proposed that looping is required for intron pairing-driven circularization. In this model, the 
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intron sequences flanking the downstream splice-donor site and the upstream splice-acceptor site 
need to be brought into close proximity to make a loop. It is hypothesized that looping can be 
provided by either of two mechanisms. One mechanism is the base pairing of inverted repeat 
elements (such as Alu elements) at both sites of circRNA which enhances looping. The other 
mechanism is the dimerization of RNA-binding proteins (RBP), such as the FUS (Fused in 
Sarcoma) protein, which binds to flanking introns (Errichelli et al, 2017). Direct back-splicing 
has a different molecular mechanism to the linear alternative splicing. In this model, two types of 
circRNAs can be produced according to whether partial intron sequences are retained, producing 
EcircRNAs, or circRNAs that contain both an intron and exon sequences (EIciRNAs) (Bahn et 
al, 2015). An example of intron pairing-driven circRNAs is Hsa-circ-POLR2A (Koh et al, 2014).  
Resplicing-driven circularization has also been proposed as a model for the generation of exonic 
circRNAs. This model requires a two-step splicing pathway, in which canonical splice sites are 
removed by initial splicing and thereby cryptic splice sites on the spliced mRNAs can be used for 






Figure 1-3: Possible models of circRNA biogenesis and different types of circRNAs.  (a) 
Lariat‐driven circularization; in this model, during a linear alternative splicing event the pre-
mRNA partially folds, and the 5′ splicing site of the upstream intron binds to 3′ splicing site of 
the downstream intron results in a spliced-out intron lariat contains skipped exons. This lariat 
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precursor then can lead to the formation of circRNA when the lariat undergoes internal back-
splicing. (b) Intron‐pairing‐driven circularization; In this model, the intron sequences flanking 
the downstream splice-donor site and the upstream splice-acceptor site need to be brought into 
close proximity to make a loop. This process is named looping and can be facilitates by either 
base pairing of inverted repeat elements at both sites of circRNA or the dimerization of RBPs 
that bind to flanking introns. (c) Resplicing‐driven circularization; This model requires a two-
step splicing pathway. The circularization can occur on the spliced mRNAs using cryptic splice 





1.1.5 circRNA functions 
1.1.5.1 MicroRNA Sponge 
To date, the biological functions of only a minor proportion of the known circRNAs have been 
studied. However, it is generally agreed that some circRNAs can play a role as super sponges for 
miRNAs and thus regulate their function (Hansen et al, 2013; Militello et al, 2017).  
MiRNAs are 18 to 25 nucleotides long ncRNAs. They are essential regulators of gene expression 
and function by binding to the 3′‐untranslated regions (3′ UTR) targeting mRNAs at specific 
miRNA recognition elements (MREs). In the majority of instances, miRNAs promote mRNA 
degradation or inhibit protein translation. Our lab and others have however also shown that 
certain miRNAs, albeit rare, can lead to mRNA stabilization (Campos-Melo et al, 2013a; Fabian 
et al, 2010; Jing et al, 2005). MiRNAs can regulate different physiological processes, such as 
hematopoiesis (Bissels et al, 2012), body development (Chen & Wang, 2012), virus defense 
(Grassmann & Jeang, 2008), cell proliferation, apoptosis (Hwang & Mendell, 2006), and fat 
metabolism (Hwang & Mendell, 2006).  
Human/mouse CDR1as (also known as cirRS-7), which is the most studied circRNA, has a high 
expression level in the human and mouse brain and acts as a sponge/inhibitor of miR-7, thus 
resulting in the promotion of the stability of miR-7 target genes and indirectly regulating many 
processes in the cells (Hansen et al, 2013; Memczak et al, 2013).  For instance, as miR-7 is 
closely related to the occurrence and development of tumors, it has been proposed that alteration 
of CDR1as expression affects tumor development and occurrence (Zhong et al, 2019).   
1.1.5.2 Protein sponge 
It has been proposed that circRNAs that have RBP binding motifs may also function as sponges 
or decoys for these proteins and indirectly regulate their functions. One example of a circRNA 
functioning as a protein sponge is circMbl which is encoded from the MBNL1 gene 
(muscleblind-like protein 1) in humans and mbl in D. melanogaster. This circRNA, in humans 
and flies, harbors binding sites for mbl and MBNL1, respectively (Ashwal-Fluss et al, 2014). 
Another example is circPABPN which sequesters RBP Hu-antigen R (HUR) and thus suppresses 
the translation of nuclear poly(A) binding protein 1 (PABPN1) mRNA in HeLa cells 
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(Abdelmohsen et al, 2017). Also, circANRIL impairs pre-rRNA processing and ribosome 
biogenesis by sequestering pescadillo homologue 1 (PES1) in the macrophages and human 
vascular smooth muscle cells (Holdt et al, 2016).  
1.1.5.3 Protein scaffolding 
NcRNAs can regulate gene expression at both the transcription and post-transcriptional levels 
through physical interaction with RBPs or other ncRNAs (Turner et al, 2014). This role can also 
be generalized to circRNAs, as some studies have investigated the association of circRNAs with 
RBPs such as AGO2 and RNA Pol II (Jeck et al, 2013; Memczak et al, 2013). CircRNAs might 
have a similar role in protein interactions to mediate cellular functions. Crosslinking 
immunoprecipitation (IP) data sets have shown that there are multiple binding sites for many 
different RBPs on circRNAs sequences, supporting an interaction between them. These 
interactions suggest that circRNAs can also function as a protein scaffold to mediate complex 
formation between particular enzymes and substrates, thus enhancing protein function (Salzman, 
2016). MBL (muscleblind) protein has also been shown to directly bind to circMbl. This 
interaction is due to the presence of functional MBL binding sites on circMbl. Moreover, the 
interaction between the circMbl and MBL protein was found to modulate the splicing activity of 
MBL and regulate the pre-mRNA splicing of the host gene by competing with the canonical 
splicing machinery (Ashwal-Fluss et al, 2014). Another example is circFoxo3 that was found to 
form a ternary complex with cell cycle proteins cyclin-dependent kinase 2 (CDK2) and cyclin-
dependent kinase inhibitor 1 (p21) which blocks cell cycle progression by inhibiting CDK2 from 
interacting with cyclins A and E, which is required for cell cycle progression (Du et al, 2016). 
circFoxo3 can also interact with senescence response-associated proteins ID1, E2F1, FAK, and 
HIF1A and promotes cardiac senescence through these interactions (Du et al, 2017b). 
Some circRNAs provide a scaffold for proteins to recruit them to a specific site of action, 
including a role for circRNAs in recruiting proteins such as transcription factors, DNA or 
histone-modifying enzymes, and chromatin remodelers to DNA. For instance, knockout of 
circRHOT1 prevents hepatocellular carcinoma (HCC) proliferation, migration, and invasion 
through recruiting a specific transcription factor to the nuclear receptor subfamily 2 group F 
member 6 (NR2F6) promoter and initiating transcription (Wang et al, 2019b). One example of 
recruiting DNA modifying enzymes to the chromatin is when circFECR1 recruits Ten-eleven 
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translocation methylcytosine dioxygenase 1 (TET1) to the promotor of the Friend leukemia virus 
integration 1 (FLI1) gene to induce DNA demethylation (Chen et al, 2018). In addition, the 
nucleosome remodeling factor (NURF), which is a chromatin remodeler complex, can be 
recruited to the SRY-box transcription factor 4 (SOX4) promoter by circDONSON and promotes 
gastric cancer proliferation, migration, and invasion (Ding et al, 2019). 
One of the suggested functions for circRNAs is regulation of transcription through enhancing 
RNA polymerase II (RNA pol II) function in the nucleus. Some of the exon-intron circRNAs 
(EIciRNAs) which localize in the nucleus interact with U1 snRNP and associate with RNA pol II 
to enhance the expression of their own host genes (Li et al, 2015c). In a study, the exon-intron 
circRNA EIciEIF3J was found to associate with RNA polymerase II in human cells. These 
nuclear-localized ElciRNAs interact with U1 snRNP and the RNA Pol II transcription complex 
at the promoter of its parental gene Eukaryotic translation initiation factor 3 subunit J (EIF3J) 
and enhances its expression (Li et al, 2015c). EIciPAIP2 is also another EIciRNA that regulate 
the expression of its parental gene by interacting with U1 snRNP and the RNA Pol II 
transcription complex. Depletion of these two circRNAs resulted in down regulation of their 
parental genes (EIF3J or PAIP2 genes, respectively) (Li et al, 2015c). 
1.1.5.4 Template for translation 
There is emerging evidence that endogenous circRNAs can be translationally active.  However, 
polysome profiling has shown that this is an uncommon property of circRNAs in that the 
majority of circRNAs show no evidence for translational activity (Guo et al, 2014a). The first 
evidence for the endogenous translational capacity of circRNAs in eukaryotes was obtained from 
the study of circ-ZNF609. Circ-ZNF609 has been shown to contain a start codon and an in-frame 
stop codon, which is created upon circularization. This circRNA, which participates in the 
regulation of myoblast proliferation and is associated with heavy polysomes, is translated to a 
protein through a cap-independent, splicing dependent mechanism (Legnini et al, 2017). It has 
also been reported that a subset of circRNAs expressed in Drosophila are associated with 
translating ribosomes, including circMblV5, circCdiV5, and circPde8V5. Interestingly, circMbl 
circRNA encodes a 37.04 kDa protein which is different from those proteins produced by any of 
the other known MBL isoforms (Pamudurti et al, 2017).  
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Lacking polyA tail and cap structures in circRNAs makes them to undergo another type of 
translation mechanism called Cap-independent translation. This type of translation, requiring an 
internal ribosome entry site (IRES), was initially discovered in viral RNAs (Pelletier & 
Sonenberg, 1988) and then identified in cellular RNAs (Weingarten-Gabbay et al, 2016). Several 
lines of evidence indicate that the insertion of the IRES and reading frames to a synthesized 
circRNA could lead to their translation in vitro (Abe et al, 2015; Chen & Sarnow, 1995; Wang & 
Wang, 2015). Therefore, endogenous circRNAs derived from the protein-coding DNA sequence, 
for example, those with ATG translational start site, might be able to translate into functional 
proteins (Guo et al, 2014b; Jeck et al, 2013). 
1.1.5.5 Transporting molecules and information 
CircRNAs have been found in exosomes which are critical mediators in the exchange of 
molecules and information between cells (Li et al, 2015b). Studies show that exosomes, which 
are released by the majority of cell types, play roles not only in normal physiological conditions 
but also in pathological conditions. An alteration of circRNAs levels in exosomes has been 
reported in recent studies. Moreover, emerging evidence shows that certain exosomal circRNAs 
play critical roles in pathological conditions such as cancer (Wang et al, 2019a). 
It has been suggested that exosomal circRNAs may play a role as intercellular signaling 
molecules to transport molecules and information. For instance, ciRS-122 which is transported 
inside exosomes from drug-resistant colorectal cancer (CRC) cells to sensitive ones, accelerates 
glycolysis and improves chemoresistance in sensitive CRC cells. This circRNA does this 
function through sponging miR-122 which results in upregulation of pyruvate kinase M2 
(PKM2) (Hon et al, 2019; Wang et al, 2019a). 
1.1.5.6 Generating pseudogenes 
The computational examination  of the mouse and human reference genomes has recognized 
several circRNA-derived pseudogenes (Dong et al, 2016; Zhang et al, 2004). This data suggested 
that some stabilized circRNAs can undergo reverse transcription and integration into the genome 
as pseudogenes. In the mouse genome, an analysis of the circRFWD2 corresponding circle locus 
(exon 6-exon 2) has revealed several circRFWD2-derived pseudogenes and 6 exon sequences 
outside of the circRFWD2-containing pseudogene. Given that most circRFWD2-related 
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pseudogenes do not contain poly (A) sequences, the mechanism of retrotranscription remains 
unknown.  
The six main functions that have been proposed for circRNAs are shown in the schematic 





Figure 1-4: Schematic representation of the six main functions of circRNA. 1)MiRNA 
sponging activity: There are multiple binding sites for miRNAs on some of the circRNAs 
sequence which provides miRNA sponging function for circRNAs. 2) Protein sponging activity: 
CircRNAs can sponge RBPs and indirectly regulate their functions. 3) Protein scaffolding 
activity: A) Protein scaffolding activity: CircRNAs can act as scaffolds to mediate complex 
formation between particular enzymes and substrates. B) CircRNAs can act as scaffolds to 
recruit proteins such as transcription factors, DNA or histone-modifying enzymes, and chromatin 
remodelers to DNA. C) Nuclear circRNAs can associate with RNA polymerase II and enhance 
its function and regulate gene expression. 4) Translational activity: A group of circRNAs have 
the ability to be translated to peptides although the majority of circRNAs provide no evidence for 
translation. 5) Transporting molecules and information: A huge number of stable circRNAs are 
found in exosomes which may play a role as intercellular signaling molecules to transport 
substances and information. 6) Generating pseudogenes: stabilized circRNAs could undergo 
reverse transcription and integrate into the genome as pseudogenes. 
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1.1.6 CircRNAs in CNS 
The expression of genes in the brain demands extreme control and regulation through the various 
brain developmental stages of an organism. Non-coding RNAs play a significant role in 
regulating different brain developmental stages as well as synaptogenesis, neurite outgrowth, 
neuronal maturation, synaptic plasticity. Newly discovered circRNAs that are highly expressed 
in the mammalian brain have emerged as novel regulatory non-coding RNAs, although their 
specific roles in the central nervous system are just starting to be elucidated (Ma et al, 2020; Xie 
et al, 2017). Almost one-fifth of the protein-coding genes in the brain generate circRNAs. 
Studies show that the expression pattern of circRNAs differs from one region of the brain to the 
other as well as in different developmental stages. For instance, circRims2, circEl2, and circDym 
are expressed at a high level in the cerebellum, while circPlxnd1 is enriched in the cortex. For 
some of these circRNAs, specific functions were found; for example, circRims2 is probably 
involved in neuronal differentiation and developmental processes (Venø et al, 2015a) but the 
functions of circEl2 and circDym remain to be elucidated (Wang et al, 2021).  
CircRNAs have been found in the dendrites of neurons using fluorescent in situ hybridization 
(FISH). Several neuronal circRNAs have been shown to undergo significant up or 
downregulation in response to homeostatic changes related to neuronal activity. An alteration in 
circRNAs expression also occurs during synaptogenesis, suggesting their potential role in the 
regulation of synaptic function (You et al, 2015). 
Interestingly, the expression level of circRNAs does not always correspond to the expression 
level of their linear counterparts.  For example, circMyst4, circKlhl2, and circAagab significantly 
overexpress during synaptogenesis while their linear cognates show downregulation (Hanan et 
al, 2017). There is also evidence that on average that the ratio of circRNA abundance to the 
relative transcript abundance is higher in the brain when a host gene is expressed in the brain as 
well as other tissue(s) (You et al, 2015). This suggests that certain circRNAs might also play 
biological roles independent from their linear host genes. CircRNAs are not only more 
abundantly and diversely expressed in the brain, but they are also differentially expressed in the 
different regions and cell types of the brain (Jeck et al, 2013; Venø et al, 2015b). Although the 
function of circRNAs in the brain is the subject of considerable interest, little is known.  So far, 
suggested physiological functions include potential regulatory roles through miRNA sponging, 
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regulation of transcriptional activities in neurons, and protein and RNA transport within the cells. 
For example, knock-out study of CDR1as in the murine brain showed a downregulation in the 
expression of miR-7 and miR-671 that directly interact with CDR1as. Subsequently, the 
expression of target genes of these miRNAs was altered in the brain of mutant mouse which 
affected neuropsychiatric-like behavior of CDR1as knock-out mice. Moreover, CDR1as knock-
out mice have dysfunctional synaptic transmission in excitatory neurons suggesting a role of 
CDR1as in regulating synaptic transmission (Piwecka et al, 2017). 
1.1.7  CircRNA in neurodegenerative disease 
Although the role of circRNAs in the pathogenesis of neurodegenerative disorders is just 
beginning to be elucidated, several studies have proposed a strong connection between circRNAs 
and nervous system diseases. Some of the important circRNAs linked to nervous system diseases 
are circzip-2 in Parkinson’s disease (Kumar et al, 2018); CDR1as/ciRS-7 in Alzheimer’s disease 
(Lukiw, 2013); IQCK, MAP4K3, EFCAB11, DTNA, and MCTP1 circRNAs in multiple system 
atrophy (MSA) (Chen et al, 2016a); circDLGAP4 in cerebrovascular diseases (Bai et al, 2018); 
and circ-TTBK2, cZNF292, and circ-FBXW7 in glioblastoma multiforme (GBM) (Yang et al, 
2016; Yang et al, 2018; Zheng et al, 2017). 
The high expression of circRNAs in the mammalian nervous system would provide novel insight 
into the studies of the pathogenesis of neurodegenerative disease. For example, miR-7 regulates 
aggregation and inhibition of α-synuclein, a protein involved in Parkinson's disease. ciRS-
7/CDR1as is an inhibitor of miR-7, which may point towards the participation of ciRS-
7/CDR1as in Parkinson's disease (Asikainen et al, 2010; Doxakis, 2010; Miñones-Moyano et al, 
2011). In addition, one interaction study revealed that circzip-2 possibly sponges miR-60 
towards asserting an important role in various processes associated with PD (Kumar et al, 2018). 
ciRS-7/CDR1as, which is a super sponge and inhibitor of miR-7, is reported to be downregulated 
in Alzheimer's disease, while miR-7 is upregulated. This ciRS-7/miR-7 axis can alter the 
expression of proteins associated with Alzheimer's disease such as ubiquitin-linked protein ligase 
A (Lukiw, 2013). Age-related overexpression of circRNAs in CNS tissues is observed across 
different species suggesting their potential role in aging and age-related diseases in the central 
nervous system such as ALS. Interestingly, this age accumulation of circRNAs is independent to 
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the mRNA expression of their parental genes (Cai et al, 2019). There is also increasing use of 
circRNAs as an indicator of aging (Westholm et al, 2014).  
Although the participation of circRNAs in neurodegenerative diseases is starting to be 
elucidated, the broader picture lacks clarity as more experimental studies are required to identify 
their targets and the mechanism of regulation. So far, very little is known about the participation 
of circRNAs in ALS pathogenesis. A study characterized several circRNAs that are affected by 
the knock-out of FUS and by FUS mutations associated with familial forms of ALS. This study 
revealed that FUS could bind to circularizing exon-intron junctions of circRNAs and regulate 
their back-splicing (Errichelli et al, 2017). In addition, another study presented the first circRNA 
differential expression analysis in PBMCs samples from patients with amyotrophic lateral 
sclerosis. Microarray-based circRNA expression profiling in this study on a subset of samples 
from ALS patients compared to controls revealed 274 upregulated and 151 downregulated 
circRNAs. This study suggests that circRNAs have the potential of being blood biomarkers for 




1.2 Amyotrophic lateral sclerosis 
1.2.1 Overview 
Amyotrophic lateral sclerosis (ALS) is a fatal and progressive neurodegenerative disorder. ALS 
is also known as Charcot disease in honor of the first person who described the disease in 1869, 
Jean-Martin Charcot.  The progression of ALS is rapid and results in progressive paralysis 
because of loss of the upper and lower motor neurons in the spinal cord and brain (Strong et al, 
2005). Respiratory failure is the main cause of death in ALS patients although heart failure and 
pulmonary embolism cause death in a minority of patients (Corcia et al, 2008). Male sex (until 
menopausal age for women when rates become equal), aging, a family history of ALS, and 
smoking are considered risk factors of ALS. The mean age of onset of ALS varies across 
populations and across historical cohorts; however, it is reported that it is usually from 50 to 65 
years with 5% of the cases having an onset <30 years of age (Byrne et al, 2013; Zarei et al, 
2015).  
While the classical concept of ALS is that of a pure motor neuron disorder, ALS is now 
considered to be a multisystem degenerative process in which frontotemporal dysfunction can be 
prominent, including cognitive and behavioral disruptions similar to those observed in 
frontotemporal dementia (FTD) (Burke et al, 2017). There are also pathological and genetic 
overlaps between these two disorders that support the concept of a disease spectrum that includes 
both ALS and FTD (De Silva et al, 2016).  
ALS is classified into three variants: sporadic (90-95%), familial (5-10%), and a previously 
hyperendemic Western Pacific variant (Garruto, 1991). Familial ALS (fALS) has prominent 
genetically inherited components although almost all of the genetic mutations associated with 
fALS have also been found in sporadic ALS (sALS) (Andersen & Al-Chalabi, 2011). The 
combination of upper and lower motor neuron degeneration causes various signs and symptoms 
that are the clinical hallmark of ALS. Weakness, muscle atrophy, and fasciculations are 
designated as lower motor neuron signs, whereas hyperreflexia and hypertonia are consistent 
with upper motor neuron involvement. For the diagnosis of ALS, clinicians consider criteria that 
support both upper and lower motor neuron impairment with involvement of at least three 
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regions of the body; the bulbar region and at least two spinal regions or in three spinal regions 
(de Carvalho et al, 2008; Li et al, 2017a; Traynor et al, 2000).  
Unfortunately, because the pathophysiology of ALS remains poorly understood, a cure has not 
been discovered yet. However, there are lots of effective treatments for ALS such as Riluzole 
and Edaravone which are currently the only FDA-approved drug treatments that are associated 
with an increase in disease duration (Miller et al, 2003; Rothstein, 2017).  
Given that the molecular mechanisms underlying motor neuron degeneration in ALS are not yet 
fully understood, illuminating the role of alterations in gene expression can provide expanding 
strategies for more effective treatments. To now, several hypotheses have been suggested for the 
pathogenesis of ALS. Structural and functional abnormalities of mitochondria, glutamate 
excitotoxicity, oxidative stress, and impaired axonal structure are the most frequently studied 
amongst these (Rothstein, 2009). 
1.2.2  Genetics of amyotrophic lateral sclerosis 
Although sALS accounts for more than 90 % of ALS cases, 5-10 % of cases are associated with 
a family history. A clear Mendelian inheritance pattern, which is primarily autosomal dominant, 
has led to the identification of a specific and broad array of genetic mutations in fALS (Taylor et 
al, 2016). Several of the gene mutations found in fALS have been also observed in sALS cases 
(Al-Chalabi & Hardiman, 2013). Over 25 genes have been found to be associate with ALS with 
several being considered to be causative (Andersen & Al-Chalabi, 2011). Among these latter 
genes, mutations in four are responsible for the majority of fALS cases, including superoxidase 
dismutase 1  (SOD1) (Rosen et al, 1993), TAR DNA-binding protein 43 (TARDBP) (Sreedharan 
et al, 2008), fused in sarcoma (FUS) (Deng et al, 2010) and Chromosome 9 open reading frame 
72 (C9orf72) (DeJesus-Hernandez et al, 2011).  
The first gene associated with fALS was SOD1, which encodes for copper/zinc ion-binding 
SOD1.  A significant difference has been observed regarding the frequency of SOD1 mutations 
in ALS between different populations. For example, SOD1 mutations account for 14.8% of cases 
of fALS and 1.2% of sALS in the European population, while in Asian populations, SOD1 
mutations account for 30.0% of cases of fALS and 1.5% of sALS (Zou et al, 2017). So far, 
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several mechanisms have been proposed for mutated SOD1 toxicity in ALS (Gaudette, 2000; 
Guareschi et al, 2012; Higgins et al, 2003; Nagai et al, 2007). Most however suggest that these 
mutations are responsible for structural instability of SOD1 that causes protein misfolding which 
results in its aggregation in motor neurons (Rosen et al, 1993; Rotunno & Bosco, 2013). 
Mutations in TARDBP that encodes TAR DNA-binding protein 43 (TDP-43) are responsible for 
the cytoplasmic mislocalization and aggregation of TDP-43 in the brain and spinal cord of ALS 
patients (Braak et al, 2013). FUS, which codes for Fused in sarcoma/translated in liposarcoma 
(FUS/TLS or FUS), is a nuclear RNA-binding protein that is mutated in a small percentage of 
fALS cases and is mislocalized from the nucleus to the cytoplasm where it accumulates as 
protein inclusions (Gal et al, 2011). Most genetic mutations involved in ALS are missense 
substitutions, although C9orf72 is mutated to have enormous expansions of an intronic 
hexanucleotide repeat. These expansions were first characterized in patients with FTD, then in 
ALS (DeJesus-Hernandez et al, 2011; Renton et al, 2011).  
The majority of these mutations are inherited in an autosomal-dominant manner. ALS-associated 
genetic mutations can be categorized into subsets by similar proposed mechanisms such as 
disruption in RNA metabolism, protein trafficking, and degradation, cytoskeletal and axonal 
dynamics (Brown & Al-Chalabi, 2017; Ling et al, 2013; Strong, 2010). A list of genes with 
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(Simpson et al, 2009) 
ARHGEF28 5q13.2 RGNEF    
RNA-binding protein 







<1% <1% Yes 
RNA-binding protein 









   
RNA splicing, mRNA 
processing (Kim et al, 
2013) 




















al, 2011; Renton et al, 
2011) 
ALS2 2q33.1 Alsin    
Endosomal dynamics 
and trafficking (Hadano 





   
Vesicle trafficking (Lee 




body protein 2b 
   
Protein trafficking to 
lysosomes (Parkinson 







<1% <1%  
Autophagy adaptor 
(Fecto et al, 2011; 




Optineurin 4% <1% Yes 
 Autophagy adaptor 





<1% <1%  
Lipid transport from 
ER, mitochondrial 
axonal transport (Luty 




Ubiquilin-2 <1% <1% Yes 
Autophagy adaptor 





   
Autophagy regulation, 
endosomal trafficking 
to Golgi network 







1–2% <1%  
Ubiquitin segregase 




10 % ?  
autophagy and 
activation of innate 
immunity  (Freischmidt 
et al, 2015; Li et al, 
2018a; Oakes et al, 
2017) 
Cytoskeletal and axonal dynamics 
PFN1 17p13.2 Profilin 1 <1% <1%  
Actin-binding protein 






Spatacsin    
Cytoskeletal stability 
(Orlacchio et al, 2010) 
PRPH 12q13.12 Peripherin    
Cytoskeletal protein 





   
maintenance of 
neuronal caliber 
(Figlewicz et al, 1994 ) 
NEK1 4q33 
NIMA (Never In 
Mitosis Gene A)-
Related Kinase 1 
   
DNA damage response, 
neuronal morphology 




<1% <1%  
Microtubule subunit 














20% 2% Yes 
Superoxide dismutase 






   
Neuronal 
differentiation 














   
Chromatin remodeling 




   
Regulation of neuronal 
membrane 
composition (Rainier et 
al, 2008) 
PON1-3 7q21.3 Paraoxonase 1-3    
Enzymatic breakdown 
of nerve toxins (Saeed 




   
Regulate D-serin level 





   
Cholinergic 
Neurotransmission 
(Sabatelli et al, 2009) 
ALS3 18q21 ALS3 <1% <1%  
Disulfide redox protein 
(Hand et al, 2002) 
*The empty cells indicate unknown values. 
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1.2.3 Neuropathology of ALS 
The classic pathology of ALS is characterized by the loss of descending supraspinal motor 
neurons, both spinal and bulbar lower motor neurons and the associated corticospinal tract (CST) 
and motor nerves. Reactive gliosis, an inflammatory response to the degeneration of the 
neighboring motor neurons, is also observed (Leigh et al, 1988; Schiffer et al, 1996).  A hallmark 
of ALS is the presence of neuronal cytoplasmic inclusions (NCI) that are categorized by their 
morphology, reaction with various histologic stains, and by immuno-reactivity for associated 
proteins (Saberi et al, 2015). At the protein aggregate level, these pathological intracellular 
protein aggregates are multiple forms of inclusion bodies that have been described for ALS in 
the motor neurons, including Bunina bodies, which are ubiquitin-negative inclusions; basophilic 
inclusions; and ubiquitinated inclusions such as round bodies, skein-like inclusions, and hyaline 
inclusions (Bäumer et al, 2010). Skein-like inclusions, which are TDP-43 positive inclusions, are 
the most common inclusions observed and are present in approximately 90% of ALS patients 
(Saberi et al, 2015).  
1.2.4 Altered RNA Metabolism in ALS 
Dynamic regulation of events occurring from genes to proteins must be strictly controlled. This 
regulation happens during the transcriptional and post-transcriptional events of mRNA, including 
pre-mRNA splicing, mRNA processing, editing, transport, stabilization and translation, and 
degradation. The disruption of normal RNA transport and metabolism has been proposed to be 
the functional consequence of several of the genetic mutations linked to ALS. Several genetic 
mutations associated with ALS exist in RBPs coding genes such as TARDBP, FUS/TLS, TAF15, 
and ARHGEF28 which are involved in gene transcription, RNA stability, RNA transport, RNA 
translation, and ribonucleoprotein (RNP) granule formation Table 1-2: Genetics of ALS.. These 
RBPs have been shown to be present in NCIs in motor neurons. RNA transcripts resulting from 
the hexanucleotide repeat expansion of the C9orf72 gene have been shown to form RNA foci 
that could sequester RBPs and disrupt their normal functions (DeJesus-Hernandez et al, 2011). In 
addition, extensive alterations in the expression of coding and non-coding RNAs have been 
reported in ALS, which supports the idea of ALS as a disorder of RNA metabolism  (Bergeron et 
al, 1994; Lin et al, 1998; Mu et al, 1996; Roberts et al, 2014; Strong, 2010).  
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MRNAs have different half-lives, ranging from those short-lived mRNA involved in signaling 
pathways to long-lived mRNAs, which are translating to housekeeping proteins. The regulation 
of mRNA turnover is crucial because it affects transcriptional rates (Bolognani & Perrone‐
Bizzozero, 2008; Hargrove & Schmidt, 1989). There is a growing body of evidence that in the 
majority of ALS cases, alterations in the metabolism of RNA underpins the disease process.  In 
the next section, I will address aspects of RNA metabolism that are dysregulated in ALS. 
1.2.4.1 RNA splicing 
Motor neurons have been shown to be susceptible to defects in RNA metabolism. For example, 
in spinal muscular atrophy (SMA) in which lower motor neurons progressively degenerate, the 
causative gene, survival motor neuron (SMN), encodes for a RBP with known roles in splicing. 
Two highly homologous SMN variants have been found, including SMN1 which is responsible 
for the production of the majority of functional SMN protein, and SMN2 which is responsible for 
the production of less protein. SMA occurs when the SMN1 gene is lost and the presence of 
SMN2 cannot compensate for the deficit in SMN protein levels. SMN protein complex interacts 
with specific spliceosome proteins and plays a role in the biogenesis of spliceosomal small 
nuclear ribonucleoproteins as well as the assembly, metabolism, and transport of several 
ribonucleoproteins (Kolb et al, 2007; Mourelatos et al, 2001). A higher level of SMN protein is 
required for the normal function of motor neurons than other types of cells (Burghes & Beattie, 
2009). It is reported that lower SMN2 copy numbers and lower levels of estimated SMN protein 
increase susceptibility to and severity of ALS (Veldink et al, 2005).  
Several RBPs associated with ALS are involved in mRNA splicing, such as TDP-43, FUS, 
heterogeneous nuclear ribonucleoprotein A1 (hnRNP1), heterogeneous nuclear ribonucleoprotein 
A2/B1 (hnRNPA2B1), and valosin-containing protein (VCP). Therefore mis-splicing of mRNA 
is a common consequence of dysregulation of ALS-related RBPs. For example, TDP-43 
participates in dysregulation of mRNA splicing of several genes including hnRNPA1, human 
cystic fibrosis transmembrane conductance regulator (CFTR), SMN2, and STMN2. TDP-43 plays 
a role in the regulation of alternative splicing of hnRNPA1 by binding to HNRNPA1 pre-mRNA 
and modulate its splicing. Thus, TDP-43 mislocalization may contribute to altered HNRNPA1 
pre-mRNA splicing in ALS (Deshaies et al, 2018). TDP-43 also participates in the promotion of 
exon skipping in CFTR mRNA (Buratti et al, 2001) and exon inclusion of  SMN2 pre-mRNA 
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(Bose et al, 2008). Klim et al. showed that the expression of STMN2 which encodes a mediator 
of neuronal growth and axonal regeneration is decreased by mislocalization or knock-down of 
TDP-43 within iPSC (Induced Pluripotent Stem Cells)-derived motor neurons. They showed that 
TDP-43 mislocalization or depletion causes the production of a cryptic exon in STMN2 mRNA 
which prevents protein production through early termination of translation (Klim et al, 2019). 
Regulation of splicing of several transcripts by FUS has been also reported to occur in the central 
nervous system. FUS interacts with the spliceosome and the splicing factors then directly binds 
to target pre-mRNAs and regulates their splicing. Thus, mislocalization of FUS to the cytoplasm 
and pathological mutations of its gene in ALS might result in aberrant alternative splicing of its 
target genes (Orozco & Edbauer, 2013). An example of endogenous neuronal splicing targets for 
FUS is microtubule-associated protein tau (MAPT encoding tau protein) (Orozco et al, 2012). 
Tau is one of the most studied proteins in neurodegenerative disease such as ALS. FUS depletion 
in rat neurons results in an aberrant alternative splicing of tau transcripts. It is also reported that 
FUS interact with tau transcripts in brain (Orozco et al, 2012).  
ALS-linked mutations in the VCP gene have been shown to cause intron retention in a nuclear 
protein named Splicing Factor Proline and Glutamine rich (SFPQ) transcript through aberrant 
splicing (Luisier et al, 2018). This intron retention results in nuclear depletion and cytoplasmic 
aggregation of SFPQ protein in the motor neuron of ALS patients. 
Another example of dysregulated RNA splicing in ALS occurs when the PRPH (peripherin) 
gene, which is one of the ALS-associated genes, is transcribing. The Per 28 isoform is a toxic 
splice variant of peripherin that is associated with NCIs in spinal motor neurons in ALS (Corbo 
& Hays, 1992). This type of dysregulation has been also observed in the case of the excitatory 
amino acid transporter 2 (EAAT2) gene for which abnormal mRNA splice variants are observed 
in the brain of ALS patients (Lin et al, 1998). 
1.2.4.2 mRNA stability 
Neurofilaments, peripherin (PRPH), and α-internexin (INA) are neuronal intermediate filaments 
(IFs) that are essential components providing neuronal structures.  There are three types of 
neurofilaments that are defined by their molecular weight, including neurofilament light (NFL), 
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medium (NFM), and heavy (NFH). Several of these IFs form pathological NCI in motor neurons 
of ALS patients (Hirano et al, 1984; Strong et al, 2005).  
TDP-43, Rho guanine nucleotide exchange factor (RGNEF), SOD1, and 14-3-3 protein have 
been shown to regulate mRNA stability of several ALS-related proteins, such as NEFL through 
binding to 3′ UTR region of their transcripts (Droppelmann et al, 2013a; Ge et al, 2007; Ge et al, 
2005; Strong et al, 2007; Volkening et al, 2009). Interestingly, the aggregation of neurofilament 
proteins in ALS is associated with alterations in NEFL mRNA stability with quantitative in situ 
hybridization of NEFL transcript demonstrating a significant decrease in its expression in ALS 
spinal motor neurons compared to control patients (Bergeron et al, 1994; Wong et al, 2000). 
RNA stability also can be affected by miRNAs, which are highly abundant and conserved small 
non-coding RNAs derived from endogenous genes. MiRNAs are single-stranded RNAs that 
control RNA expression and stability (Fabian et al, 2010). They are increasingly recognized to 
play a crucial role in the regulation of neuronal development and function and participate in 
neuronal degeneration (Davis et al, 2015). Previously our lab described the miRNA 
expression profile in the spinal cord of ALS patients compared to controls (Campos-Melo et al, 
2013a). This study showed significant differential expression of a large group of miRNAs, which 
is another sign of altered RNA metabolism in ALS. This study also examined the effect of those 
population of miRNAs which have MREs within the human NEFL mRNA 3′ UTR on NEFL 
mRNA expression. Among these miRNAs, there is a group (miR-146a*, 524-5p, and 582-3p) 
that directly downregulates the NEFL mRNA, suggesting an involvement in the altered stability 
of the NEFL mRNA in the spinal motor neurons in ALS (Campos-Melo et al, 2013b). Further 
research in our lab also has described the role of miR-105 and miR-9 in the regulation of NEFL 
expression  and which are down-regulated within the spinal cord of ALS patients (Hawley et al, 
2019). 
1.2.4.3 RNA transport 
Dyneins and the kinesin superfamily proteins (KIFs) are known to participate in the 
transportation of RNP granules along dendrites and axons. Dynein is a microtubule minus end-
directed motor that is required for retrograde axonal transport. Dynein also plays roles in mRNA 
localization and neurofilament transport. Mutation in dynein heavy chain which has a function in 
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the microtubule motor dynein complex formation has been found in a progressive motor 
neuronopathy and severe impairments in retrograde signaling. Dynein plays its role in retrograde 
signaling in association with a protein complex named dynactin that has been found to have 
mutations in some cases of ALS (Hafezparast et al, 2003; Münch et al, 2005; Puls et al, 2003). 
Although no mutations related to disrupting RNA transport in kinesin superfamily proteins have 
been yet reported, one study showed that downregulation of the kinesin-associated protein 3 
(KIFAP3) is associated with enhanced survival in sALS (Landers et al, 2009).  
Insulin-like growth factor II mRNA-binding protein 1 (IMP1), associated with FUS protein, is 
involved in the recruitment and transportation of target mRNAs to cytoplasmic complexes in 
neurons. This protein is found in FUS-positive cytoplasmic inclusions when FUS is mutated, 
suggesting that FUS mutations might alter the transportation of mRNA targets of IMP 
(Kamelgarn et al, 2016). In addition, the localization of the discoidin domain tyrosine kinase 
receptor 2 (DDR2) and KN motif and ankyrin repeat domains 2 (Kank2) transcripts can be 
influenced by FUS mutations (Yasuda et al, 2017).  
In addition, dysregulation of nuclear pore complexes occurs in ALS which causes the disruption 
of nucleocytoplasmic transport. Whereas insoluble TDP-43 interacts with nuclear pore 
complexes, ALS-related mutations in the TARDBP gene in mouse models and iPSC-derived 
motor neuron models showed the disruption of nucleocytoplasmic transport of polyadenylated 
transcripts (Chou et al, 2018). A similar effect has also been observed when MATR3 and 
C9ORF72 were mutated (Boehringer et al, 2017; Zhang et al, 2015). 
1.2.4.4 RNA translation 
There is evidence suggesting a relationship between RNA translation and ALS pathogenesis. 
Several mutations that are known to be causative in ALS affect RNA translation, including FUS 
and TDP-43 (Coyne et al, 2017). 
Neuronal activities depend on the localization of synaptic proteins such as signaling molecules 
and neurotransmitters (Krichevsky & Kosik, 2001). Neuronal RNP granules (also known as 
transport granules) are responsible for transporting ribosomes and temporary translationally 
arrested mRNAs in response to synaptic stimuli. Several RBPs associated with ALS play a 
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pivotal role in the assembly and regulation of these transport granules. Dysfunctional neuronal 
transport granules have been reported to be associated with ALS (Elvira et al, 2006; Kanai et al, 
2004). TDP-43 is present in neuronal transport granules and collaborates with other RBPs to 
repress the translation initiation. Mutations in TDP-43 observed in ALS affect neuronal transport 
granule trafficking and hence RNA translation (Alami et al, 2014). 
Substantial evidence implicates cellular stress as an important mechanism for motor neuron 
death. For instance, mutations in SOD1 affect the oxidative stress mechanisms in motor neurons 
and thus might cause neurodegeneration (Abe et al, 1995; Beal et al, 1997). Moreover, ALS 
patients show markers of oxidative damage in their spinal cord fluid (Bogdanov et al, 2000). 
Many RBPs associated with ALS are localized in stress granules (SGs) which are a type of RNP 
granules formed in response to stress. Therefore ALS-related mutations in these RBPs can 
dysregulate SGs assembly and disassembly. As non-translated mRNA is a key component of 
SGs, dysregulation of SGs formation and dynamics might cause disruption in translation 
(Anderson & Kedersha, 2009).  
31 
31 
1.3 Membraneless organelles 
1.3.1 Overview 
Advanced visualization technologies have revealed that in addition to membrane-bounded 
compartments, the nucleus and cytosol of eukaryotic cells contain non-membrane bounded 
macromolecular assemblies named membraneless organelles (MLOs). These biological 
assemblies are also termed biomolecular condensates. Recently discovered MLOs are highly 
dynamic macromolecular assemblies that often show liquid-like physical properties that range in 
size from nanometers to micrometers (Mitrea & Kriwacki, 2016). Despite numerous studies on 
these macromolecular assemblies, the exact functions and mechanisms underlying their 
formation are yet to be fully understood.  
A wide range of membraneless structures, from RNP granules to centrosomes and clusters of 
signaling molecules on membranes, are formed via a process called liquid-liquid phase 
separation (LLPS) (Banjade & Rosen, 2014; Li et al, 2018b; Molliex et al, 2015). The basic 
principles of phase separation of organic polymers in the solution can be described by Flory-
Huggins solution theory which delineates the free energy of a polymer-solvent mixture, where 
polymers are considered as simplified arrays of modules that represent their repetitive segments 
(Flory, 1941; Huggins, 1942). When a critical concentration or temperature threshold is crossed, 
solutions of macromolecules undergo LLPS and condense into a dense phase that coexists with a 
dilute phase (Figure 1-5). The driving force underlying this process is the exchange of 
macromolecule/water interactions for macromolecule/macromolecule and water/water 
interactions in which the polymer becomes a better solvent for itself than the solution it is 
dissolved in. LLPS enables cells to compartmentalize spatiotemporally within a boundary which 
allows dynamic trafficking of biomolecules into and out of the compartment. Moreover, the 
concentration of certain molecules within macromolecular assemblies can be increased by phase 
separation. This probably accelerates reaction rates and biochemical activities inside 







Figure 1-5: Schematic illustration of liquid-liquid phase separation. In cells, LLPS occurs 
when solutions of macromolecules such as proteins and/or nucleic acids condense into a dense 
phase that coexists with a dilute phase. This process can result in the formation of liquid droplets 




Phase separation can occur for many proteins in vitro, although not all do so under physiological 
conditions. It has been observed that proteins associated with these assemblies often contain two 
types of domains: folded domains that acquire stable secondary and tertiary structures, and 
intrinsically disordered protein regions (IDRs) that do not adopt stable secondary and tertiary 
structures. A subset of disordered protein regions is termed low complexity domains (LCD) in 
that they contain amino acid composition with little diversity. Interestingly, some proteins within 
membrane-less organelles are entirely disordered (called intrinsically disordered proteins or 
IDPs). It is proposed that the high degree of conformational flexibility and dynamics of 
membrane-less organelles arises from the over-presentation of low-complexity sequences and 
disordered regions in their protein composition. Multivalency which is achieved through the 
repetitive presence of folded domains and LCDs in proteins that are associated with phase 
separation is likely to contribute to the liquid and dynamic properties of membrane-less 
organelles. However, one of these two types of multivalent interactions is sufficient for protein 
phase separation. In other words, both folded domains and disordered/low complexity regions 
can initiate phase separation (Uversky, 2017; 2019).  
In addition to proteins, RNA self-assembly/condensation has been proposed to have an important 
role in formation of MLOs that contain RNA. Several lines of evidence have suggested the role 
of intermolecular RNA–RNA interactions in RNP granule formation. For instance, the high 
concentration of local RNA is a driving factor for the formation of many RNP granules like 
paraspeckles and histone locus bodies (Yamazaki et al, 2019). In addition, decreasing translation 
initiation or inhibiting RNA degradation which results in an increased level of untranslated 
mRNA causes higher SG and P-bodies formation, respectively (Bounedjah et al, 2014; 
Mahadevan et al, 2013) 
Biological phase separation carries an entropic cost which is counteracted by numerous weak 
interactions. This type of interaction maintains membraneless organelles in phase (Brangwynne 
et al, 2015). These important weak interactions include π–π stacking, cation-π interactions, 
charge-charge interactions, and transient cross-β-contacts. π–π stacking refers to attractive, 
noncovalent interactions between aromatic rings since they contain π bonds. π bonds happen 
where two lobes of an orbital on two atoms laterally overlap two lobes of an orbital on another 
atom. Electrons that are involved in π bonds are referred to π electrons (Matsuo & Hayakawa, 
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2018). These interactions are involved in both RNA and protein stacking. For example, aromatic 
amino acids contain delocalized π electrons which are involved in π–π interactions in proteins 
associated with LLPS (Vernon et al, 2018). Cation–π interaction is a noncovalent molecular 
interaction between the face of an electron-rich π system (e.g., electron-rich aromatic groups) 
and an adjacent cation (e.g., the positively-charged amino acids). An example of cation–π 
interaction is between FG (phenylalanine-glycine) and RG (arginine-glycine) regions of Ddx4 
RNA helicase that drives this protein into phase separation in vitro and in vivo. Moreover, 
multiple π-π interactions and cation–π interactions have the ability to disrupt the internal π-π 
interaction of nucleic acid duplexes and drive them to phase separation (Nott et al, 2016; Nott et 
al, 2015). Charge neutralization refers to a state in which the net electrical charge of polymers in 
an aqueous solution has been counteracted by the adsorption of an equal number of opposite 
charges. This charge neutralization is an important driver for phase separation and has been 
observed for mixtures of RNA and cationic peptides as well as proteins both in vitro and in vivo 
(Aumiller & Keating, 2016; Pak et al, 2016). 
A wide range of membraneless organelles exists in eukaryotic cells. Membraneless organelles 
within nuclei are also called nuclear bodies and examples of them include the nucleolus, 
paraspeckles, nuclear speckles, Cajal bodies, and PML (promyelocytic leukemia) bodies. 
Cytosolic membrane-less organelles include transport granules, SGs, processing bodies (P-
bodies), and germ granules. The majority of membraneless organelles are RNP granules (also 
called RNA granules) that consist of RBPs and RNA assembled via LLPS (Uversky, 2017). 
However, there are different types of MLOs that do not contain RNAs (e.g., SUMO-1 nuclear 
bodies, Cleavage bodies, chromatin, Insulator bodies) (Uversky, 2017). 
1.3.2  RNP granules 
RNP granules are self-assembled ribonucleoprotein complexes in nuclear and/or cytoplasmic 
structures that are not defined by membranes. These types of membraneless organelles require 
the coding and/or non-coding RNAs for their formation. Besides RNAs, RNP granules are 
composed of the proteins involving in the regulation of localized RNA translation, silencing, or 
decay (Kiebler & Bassell, 2006). RNP granules are categorized into nuclear and cytoplasmic 
RNP granules base on their cellular localization (Table 1-3 is modified from a table in Uversky's 
paper (Uversky, 2017)). RNP granules in the nucleus regulate various steps of RNA and RNP 
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processing while cytoplasmic granules regulate RNA translation, RNA degradation, signaling 
pathways, and stress responses (Kedersha et al, 2013; Trinkle-Mulcahy & Sleeman, 2017). RNA 
transport and localized translation can be regulated by  RNP transport granules in neurons and 
myogranules in skeletal muscle (Kiebler & Bassell, 2006; Vogler et al, 2018).  
RNP granule proteomes have been studied using different approaches. Initially, locally 
concentrated proteins in RNP granules have been identified using immunofluorescence 
techniques. Mass spectroscopy of RNP granules extracted by differential centrifugation or by 
particle sorting has provided a more complete identification of the protein composition of RNP 
granules (Hubstenberger et al, 2017; Jain et al, 2016). Recently, more advanced methods like 
Bio-ID or APEX labeling have been used to characterize the RNP granule proteome (Markmiller 
et al, 2018; Wheeler et al, 2016). Taken together, these approaches have revealed that RNP 
granules contain three types of RBPs. Some RBPs provide protein-based assembly and play roles 
in the formation of a specific granule; this type of RBPs can be only found in that specific 
granule. Other RBPs are carried to RNP granules by interacting with RNAs and therefore can be 
in common between different types of RNP granules. The last types are RBPs that promote 
RNA-RNA interactions by binding to the RNA embedded within RNP granules and thus can be 
found in more than one type of RNP granule (Bounedjah et al, 2014; Tauber et al, 2020). Other 
types of proteins also can be found in RNP granules. For example, proteins involved in cellular 
signaling pathways and metabolism have been found in SGs, providing evidence of the influence 
of SGs in cell signaling and metabolism (Tauber et al, 2020). The nucleolus is another example 
of RNP - that contain a vast variety of proteins besides RBPs (Boisvert et al, 2007). 
Whereas RNP granules regulate different aspects of RNA metabolism, other RNA species are 
also involved in the assembly and integrity of RNP granules. All the mRNAs contained in RNP 
granules are translationally suppressed (Brengues et al, 2005). The RNA composition of RNP 
granules is generally related to granule function. For instance, snRNAs localized to paraspeckles, 
where they are organized into snRNPs, and ribosomal RNAs localize to the nucleolus, where 
they are assembled into ribosomal subunits (Fox & Lamond, 2010; Savino et al, 2001). Specific 
types of RNAs are present in specific type of RNP granules, so the individual RNA constituents 
might be considered as the principal determinants of organelle identity. Interestingly, RNAs can 
have intermolecular interactions and thus induce their self-assemble into condensates in vitro. In 
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addition, environmental factors such as higher salt concentration can promote trans RNA-RNA 
interactions which enhance RNA condensation (Yamazaki et al, 2019).  
There are three different approaches to identifying the RNA composition of RNP granules. The 
FISH technique can be used to characterize RNA composition in RNP granules. Purification of 
RNP granules from the cells and sequencing the RNAs that are purified is another approach 
(Hubstenberger et al, 2013; Khong et al, 2017). The third approach is to identify those RNAs that 
have interactions with the main RBPs of a specific RNP granule. This method will be usually 
followed by FISH to validate the data (Lee et al, 2020).  
RNAs and proteins within RNP granules are assembled through multivalent interactions, 
including protein-protein, RNA–RNA, and protein-RNA interactions. Both well-folded domains 
and IDRs of proteins can contribute to multivalent protein-protein interactions in RNP granules. 
Interestingly, RNP granules share RNAs and RBPs that can be exchanged through dynamic 
interactions between them (Buchan & Parker, 2009; Kedersha et al, 2005). Previously, the 
transcripts that comprise different types of RNP granules have remained undetermined due to a 
lack of effective purification methods for RNP granules. In recent years, various purification 
strategies have been devised to sequence the RNAs that localize to different cytosolic RNP 
granules based on differential centrifugation, differential centrifugation followed by 
immunoprecipitation or particle sorting or differential migration through sucrose gradients (El 
Fatimy et al, 2016; Jain et al, 2016; Khong et al, 2017; Namkoong et al, 2018). Next, RNA-seq is 
used to identify the transcriptome of RNP granules (Khong et al, 2018). 
In neurons, RNP granules can be found in distinct subcellular compartments, such as the soma, 
dendrites, axons, and synapses.  In this manner, RNP granules can control the subcellular 
proteome and thus can facilitate the neurons’ ability to respond to stress. Alterations in this 
process can lead to diverse pathological events in the neurons. It has been proposed that synaptic 
localization of mRNAs is a mechanism for synaptic plasticity and thus learning and memory 
(Costa-Mattioli et al, 2009). Moreover, mRNA targeting, and local protein synthesis can 
influence axon guidance and nerve regeneration. Therefore, RNP granules are crucial structures 
for neuronal functions (Krichevsky & Kosik, 2001). RBPs associated with ALS had been 
reported to be present in the formation and function of RNP granules. Regarding the essential 
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functions and components of RNP granules, they have been considered to play critical roles in 
RNA metabolism and potentially as the precursor for NCIs in ALS (Ling et al, 2013; Wolozin, 
2012a). Neurons have different types of RNP granules, including transport granules, SGs, P-
bodies, and activity-dependent granules in the cytoplasm, and paraspeckles and nuclear bodies in 
the nucleus (Ingelfinger et al, 2002; Kedersha et al, 2000; Martin & Ephrussi, 2009; 




Table 1-3: Characteristics of currently known RNP granules. 






Sam68 nuclear bodies 
(SNBs) 
mRNA trafficking 
through the nucleus 
nucleus 10–30 300–1000 
Nuclear stress bodies (nSBs)  response to stress nucleus 4–6 2000–2500 
Oct1/PTF/transcription 
domains (OPT domains) 
response to replication 
stress 
nucleus 
One or few 
 
1000–3000 








site of ribosome 




Nuclear speckles pre-mRNA splicing nucleus 25–50 500–1000 
Promyelocytic leukemia 
(PML) nucleic bodies 
control cellular 





Cajal bodies (CBs) 
involve in snRNP 
biogenesis 
nucleus 1–5 100–2000 
Paraspeckles 
Regulation of gene 
expression through 







Protein synthesis in 













Processing bodies (P-bodies) 
Response to stress, 
mRNA decay 
Cytoplasm 2–20 100–300 
Germ cell granules 













*Table is adapted from Uversky's paper (Uversky, 2017). This reference did not specify the type 





1.3.2.1 Transport Granules  
In situ hybridization (ISH) had previously revealed the steady-state distribution of specific 
mRNAs to subcellular domains of polarized cells such as neurons. A study in live 
oligodendrocytes using fluorescently labeled and microinjected mRNA of myelin basic protein 
(MBP) showed this mRNA is involved in RNP granules formation, which transports along 
microtubules (Kiebler & Bassell, 2006). These granules were characterized as persistent, 
oscillatory, or immobile RNPs that were heterogeneous in size and were later named “RNA 
transport particles” by Wilhelm and Vale (Wilhelm & Vale, 1993). These are now called 
transport granules. They are crucial for normal cellular functioning and can be found throughout 
the cell under physiological conditions.  
Transport granules contain translational subunits such as elongation factors, ribosomal proteins, 
and clusters of ribosomes supporting the idea of the involvement of transport granules in the 
initiation of translation at their final destination (Knowles et al, 1996). Transport granules have 
been found to be localized along microtubules in neurons, suggesting an important role in RNA 
transport and a function in supporting synaptogenesis, synapse pruning, synaptic plasticity, axon 
guidance, and axonal regeneration through regulation of mRNA localization and subsequent 
local protein synthesis  (Knowles et al, 1996). Staufen (STAU), a double-stranded RBP, is a core 
component of transport granules. Staufen interacts with the 3′ UTR of mRNA targets through 
binding to the STAU1‐binding site (SBS). This interaction occurs when SBS forms a double-
stranded RNA structure through the base pairing of 3′ UTR sequences either with themselves or 
ncRNAs (Park & Maquat, 2013). These RNA secondary structures are required for recruiting 
Staufen to mRNA and the formation of transport granules. Evidence suggests that Staufen is 
responsible for the formation of transport granules and plays an important role in transporting 
specific mRNAs to the growing dendrite along microtubules in developing neurons. 
Differentiated neurons might take advantage of Staufen's functioning in transporting specific 
mRNAs to the synapse, which provide synaptic microenvironments through local protein 
synthesis (Roegiers & Jan, 2000). 
Deficits in neuronal transport contribute to the pathogenesis of multiple nervous system diseases. 
Loss of the FMRP (Fragile X Mental Retardation Protein 1) protein, encoded by the FMR1 
(fragile X mental retardation 1) gene on chromosome X, is a component of transport RNP 
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granules. FMRP is an RNA-binding protein expressed in most tissues but found predominantly 
in the brain, testes, and ovaries (Ashley et al, 1993; O'Donnell & Warren, 2002). FMRP contains 
a nuclear localization signal (NLS) and a nuclear export signal (NES), which provide shuttling 
property between the nucleus and cytoplasm of a cell (Imbert et al, 1998). FMRP is known as a 
neuronal RBP associated with polyribosomes, which plays a role in RNA translation and 
localization. (Ascano et al, 2012; Devys et al, 1993).  Loss of the FMRP protein that is a 
component of transport RNA granules and expresses from the fragile X mental retardation gene 
leads to fragile X mental retardation syndrome (Tosar et al, 2012). Moreover, loss of full-length 
SMN protein that is also a component of RNP granules transported along neurites, results in the 
autosomal recessive motor neuron disease SMA. SMN deficiency causes the changes in β-actin 
mRNA localization in the growth cones of developing neurons, which leads to reduced neurite 
outgrowth (Rossoll et al, 2003). There is evidence showing TDP-43 is one of the components of 
neuronal RNP granules (transport granules) (Alami et al, 2014). In fact, TDP-43 is physically 
associated with Staufen and FMRP to form a functional complex and regulate the expression of 
important genes such as Sirtuin 1 (SIRT1) (Yu et al, 2012). Moreover, it is reported that ALS-
linked mutant TDP-43 can impair RNA trafficking through neuronal transport granules which 
might elaborate the role of TDP-43 in RNA trafficking (Alami et al, 2014). Recently, Staufen 
was found in NCIs related to SGs containing TDP-43, FUS/TLS, and FMRP, suggesting the 
involvement of neuronal transport granules in ALS pathology (Tosar et al, 2012). 
1.3.2.2 Stress granules  
Stress granules are cytoplasmic phase‐dense structures that are formed in response to 
environmental stress (e.g., heat, oxidative conditions, UV irradiation, and hypoxia). SGs recruit 
polyadenylated mRNA transcripts, specific RBPs, and other proteins, including several initiation 
factors and small ribosomal subunits (Kedersha et al, 2000). Eukaryotic cells that are exposed to 
stress reprogram mRNA metabolism to repair stress-induced damages and adapt to changed 
conditions. Therefore, the SGs formation seems to be a protective mechanism in response to 
cellular stress. This concept is supported by the observation that inhibitors of SG assembly 
decrease cell survival of some specific cell lines under stress conditions (Eisinger-Mathason et 
al, 2008). Eukaryotic cells under stress limit the translation of a broad array of mRNAs and shift 
RNA transcription and translation to only the essential proteins required for survival (Holcik & 
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Sonenberg, 2005; Pearce & Humphrey, 2001). This switch is achieved by collecting unnecessary 
mRNAs and their associated proteins, as well as factors involved in translational repression and 
mRNA decay into SGs. A vast variety of proteins exist in SGs, including RNA-binding proteins, 
non- RNA-binding proteins (such as post-translation modification enzymes, metabolic enzymes, 
and protein or RNA remodeling complexes), and key components of signaling pathways (Khong 
et al, 2017). 
Interestingly, many RBPs involved in SG formation harbor IDRs, which provide the ability of 
self-assembly for proteins. This domain enables proteins to form reversible self-templating 
amyloid fibrils, which usually results in a decrease in the protein’s function (Protter & Parker, 
2016). Assembly and disassembly of SGs are mediated by various post-translational 
modifications as well as numerous RNP remodeling complexes. Protein-protein interactions in 
SGs can be modified by phosphorylation, methylation, and glycosylation, which influence SG 
assembly (Wheeler et al, 2016). SG assembly is initiated by the self-aggregation of the RBP T-
Cell-Restricted Intracellular Antigen-1 (TIA-1), TIA-1-related (TIAR), and Ras-GTPase-
Activating Protein SH3-Domain-Binding Protein (G3BP). TIA-1 is a key component and marker 
of SGs, rapidly and continuously shuttling in and out of SGs, suggesting that the assembly of 
SGs is a highly dynamic process (Kedersha et al, 2000). RBPs possessing IDRs can recruit target 
mRNAs with their RNA recognition motifs (RRM) into RNP granules. As aggregates formed by 
IDRs are reversible, SGs can be rapidly dissociated upon the stress dissipation, liberating the 
arrested mRNAs and translation machinery to resume their normal functions (Gilks et al, 2004). 
There is a negative correlation between SGs formation and stability of translating polysomes 
because polysome stabilization prevents SGs assembly, and disturbance of polysomes promotes 
SGs formation (Mollet et al, 2008). 
Many SG-associated RNA-binding proteins contain a glycine-rich IDR (Gilks et al, 2004). This 
specific domain has the potential to make the protein form insoluble aggregates which can be 
pathological. Therefore, many studies have started to investigate the role of SGs in the pathology 
of different diseases, specifically neurodegenerative disorders (King et al, 2012). Recently, many 
studies have been suggesting a correlation between SG formation and protein aggregate 
formation in ALS. This might be because of the contribution of ALS-related RNA-binding 
proteins in SGs formation.  Indeed, subsets of NCIs containing TDP-43 in ALS patients can be 
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labeled for SG markers such as TIA-1, eIF3 (eukaryotic translation initiation factor 3), and 
PABP (Polyadenylate-binding protein) (Dormann et al, 2010; Liu-Yesucevitz et al, 2010b; 
McGurk et al, 2014; Volkening et al, 2009). Moreover, FUS and TDP-43 have both been 
reported to colocalize with TIA-1 positive stress granules (Liu-Yesucevitz et al, 2010b; Sama et 
al, 2013). In response to cellular stress, the untranslated mRNAs enriched in some RNP granules 
including SGs. RNA-RNA interactions have been shown to have important role in SGs 
formation (Van Treeck et al, 2018). 
1.3.2.3 Processing bodies 
Like SGs, processing bodies (P-bodies) are also RNP granules that play crucial roles in mRNA 
metabolism. P-bodies are thought to participate in mRNA storage and degradation. These RNP 
granules play significant roles in controlling gene expression through the regulation of mRNA 
turnover (Decker & Parker, 1993). P-bodies were first discovered when cells that were stained 
for XRN1 exhibited an unusual punctate staining pattern (Bashkirov et al, 1997). P-bodies 
contain many other components of mRNA silencing and degradation, including RNA decapping 
machinery (Dcp1/Dcp2 decapping enzyme complex), decapping activators, exonucleases, 
mRNA deadenylases, translation repressor, nonsense-mediated decay (NMD) factors, and 
miRNA silencing complex (AGO2, RISC, GW182 (Glycine-Tryptophan Protein of 182 
kilodaltons)) (Li et al, 2013).  
P-bodies are constitutively expressed in the cells; however, translational repression induced by 
specific stressors may increase the number of these types of RNP granules. The classification of 
RNAs and RNA-binding proteins to RNP granules in cells is regulated in different manners, 
depending on various sources of cellular stress. Interestingly, although SGs and P-bodies are 
distinct foci of RNP localization, they share certain RNA-binding proteins potentially because of 
the ability of SG and P-bodies to physically interact with each other (Kedersha et al, 2005). 
Thousands of different RNAs were found to be significantly enriched in P-bodies 
(Hubstenberger et al, 2017). MRNAs were found to be the most abundant type of RNA in this 
type of RNP granules, although some long non-coding RNAs and other types of non-coding 
RNAs were also identified. Interestingly, P-bodies contain less RNA than SGs, which is 
consistent with P-bodies being much smaller than SGs (Hubstenberger et al, 2017).  
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The involvement of P-bodies in ALS pathogenesis has yet to be determined. However, like SGs, 
many RBPs in P-bodies contain low complexity domains that have the potential to form 
irreversible aggregates within the cytoplasm. In addition, the presence of ALS-associated RBPs 
such as TDP-43 and FUS in P-bodies has been reported (Volkening et al, 2009). 
1.3.2.4 Paraspeckles 
Paraspeckles are RNP granules located in the nucleus.  To date, more than 40 RBPs have been 
identified to be present in paraspeckles; however, only seven of them are essential for 
paraspeckle formation. Essential RBPs for paraspeckle formation include SFPQ, non-POU 
domain-containing octamer-binding protein (NONO or P54nrb), heterogeneous nuclear 
ribonucleoprotein K (HNRNPK), FUS, Switch/Sucrose Non-Fermentable (SWI/SNF) chromatin 
remodeling complexes, RNA Binding Motif Protein 14 (RBM14), DAZ-associated protein 1, and 
heterogeneous nuclear ribonucleoprotein H3 (HNRNPH3) (Pisani & Baron, 2019). Besides these 
RBPs, paraspeckles are composed of the lncRNA Nuclear Enriched Abundant Transcript 1 
(NEAT1). NEAT1 acts as a scaffold for paraspeckle formation. This lncRNA has two transcript 
variants, NEAT1_1 and NEAT1_2, with different sizes that both are present in the nuclear 
paraspeckles. NEAT1_2 is the longer and essential transcript for paraspeckle formation and 
regulation, while the function of NEAT1_1 in paraspeckles has remained unclear (Bond & Fox, 
2009). 
Previously, nuclear paraspeckles were considered non-essential because NEAT1 knock-out mice 
seemed to be healthy (Nakagawa et al, 2011). However, later studies have identified multiple 
functions for paraspeckles, including gene regulation through nuclear retention of RNAs and 
proteins, and miRNA formation (Fox & Lamond, 2010). Retention of specific RNAs in the 
nucleus by paraspeckles can help the cells to translate those RNAs only under specific conditions 
such as stress. Paraspeckles also sequester several nuclear proteins to modulate their functions, 
although, this sequestration does not always result in loss of function (Prasanth et al, 2005). In 
fact, the sequestered proteins preserve the ability to interact with promotor regions and influence 
gene expression (Prasanth et al, 2005). The other function that has been reported for paraspeckles 
is involvement in miRNA biogenesis. Under specific conditions, DiGeorge syndrome 
chromosomal region 8 (DGCR8), which is a subunit of the microprocessor complex involved in 
miRNA biogenesis, is localized into paraspeckles (Shiohama et al, 2007). It is found that about 
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two-thirds of the pri-miRNAs expressed in HeLa cells bound to both NONO and PSF (Jiang et 
al, 2017). Moreover, NEAT1 can facilitate the interaction between the microprocessor and 
miRNA through the formation of hairpin loops. This evidence might indicate the influence of 
paraspeckles in miRNA biogenesis (Krol, 2017).  
The exact role of paraspeckle structures in both normal and diseases condition is unknown. 
However, several studies have examined the participation of paraspeckles in various pathologies 
such as cancer, viral infection, and neurodegenerative disease. Studies demonstrate the 
overexpression of NEAT1 in several cancers including non-small lung cancer (Jen et al, 2017; 
Sun et al, 2017), hepatocellular carcinoma (Fang et al, 2017), ovarian cancer (Chen et al, 2016b; 
Ding et al, 2017), breast cancer (Ke et al, 2016; Lo et al, 2016), and prostate cancer (Li et al, 
2018c; Xiong et al, 2018), to name but a few.  In viral infection sequestration of SFPQ, a 
repressor of IL-8, in paraspeckles by NEAT1 results in the transcription of IL-8 and immune 
response stimulation (Hirose et al, 2014). 
The contribution of paraspeckles to neurodegenerative diseases has been discussed in numerous 
studies. For instance, one study showed the overexpression of NEAT1 in post-mortem brains of 
Huntington’s disease patients (Sunwoo et al, 2017). Studies have also reported the 
overexpression of NEAT1 in models of Parkinson’s disease (PD) (Liu & Lu, 2018; Pickrell & 
Youle, 2015). The upregulation of NEAT1 has also been reported in the serum of patients with 
multiple sclerosis (MS) (Santoro et al, 2016).  
The role of paraspeckles in the pathology of ALS has been of recent interest. Seven of the 40 
RBPs involved in paraspeckle formation and function are encoded by genes mutated in familial 
forms of ALS, including TARDBP and FUS (Hennig et al, 2015). ALS patients with FUS 
mutation (ALS-FUS) showed hyper-assembly of paraspeckles in their spinal neurons (An et al, 
2019). In addition, ALS-FUS patients have been shown to have a pathological accumulation of 
NONO in their spinal cord neurons. This evidence is in line with the observation of NONO 
aggregation in cellular and mouse models of ALS-FUS (Shelkovnikova et al, 2014). 
Interestingly, RNA-FISH using DIG-labeled NEAT1_2 probe in the motor neuron of ALS and 
control patients showed that NEAT1_2, which is an essential component for paraspeckle 
formation, is not normally expressed in most motor neurons of control patients. However, it is 
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expressed in the early stages of ALS neurodegeneration and induces paraspeckles formation in 
the motor neurons of ALS patients (Nishimoto et al, 2013). Whereas, FUS is one of the essential 
components of paraspeckles, the loss of FUS from the nucleus can alter the stability of 
paraspeckles by mis-regulating NEAT1 steady-state levels or even loss of paraspeckles, which 
might impact the cell response to the stress (Shelkovnikova et al, 2014). It is also shown in a 
mouse model of FUSopathy, the mis-localized FUS sequestered other essential paraspeckle 
proteins into NCIs. ALS-related mutation in FUS also results in colocalization of FUS and other 
essential paraspeckle proteins into cytoplasmic protein inclusions in cultured cells. Therefore, 
pathological FUS mutations might affect paraspeckle function in ALS. Despite these findings, 
the physiological significance of the formation of paraspeckles during ALS pathogenesis remains 
to be elucidated (Shelkovnikova et al, 2014). 
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1.4 Relevance to the current study 
Despite considerable research efforts, the biological basis of ALS has remained unclear. Several 
studies have revealed the role of cellular stress in the pathogenesis of ALS. Eukaryotic cells use 
a variety of strategies to preserve themselves against a barrage of cellular stresses, such as 
chemical exposures, oxidative stress, heat shock, and even aging. Under stress, the top priority of 
cells is survival and recovery; therefore, they conserve resources through limiting translation and 
producing just the essential proteins required for survival (Lindquist, 1981). Stressed cells keep 
non-translating mRNAs and their associated RBPs in RNP granules such as SGs and P-bodies 
(Anderson & Kedersha, 2008). Interestingly, many RBPs associated with ALS, such as FUS and 
TDP-43, colocalize with several SG markers in cultured cells and primary neurons under stress. 
Moreover, colocalization of cytoplasmic inclusion of FUS and TDP-43 with SGs marker has 
been observed in post-mortem samples from ALS and FTD patients (Liu-Yesucevitz et al, 
2010a; Wolozin, 2012b). Therefore, it is suggested that cytoplasmic localization of ALS- 
associated RBPs to SGs could serve as a critical pathway for ALS.  
The study of transcriptome of RNP granules has shown that, besides RBPs, non-translating 
mRNAs and some non-coding RNAs are present in RNP granules (Tian et al, 2020). Thus, the 
study of the RNA component of RNP granules might help to better understand the role of 
cellular stress and RNP granules in ALS pathogenesis. In addition, massive dysregulation in the 
expression of coding and non-coding RNAs has been reported in ALS. Therefore, the study of 
the presence of these dysregulated RNAs in RNP granules or their participation in RNP granule 
formation and function might shed further light on the pathogenesis of ALS.  
Non-coding RNAs have been recognized to be abundantly expressed in the mammalian central 
nervous system and to play important roles in neurodegenerative disorders (ABDULLA & 
CAMPBELL, 1997). CircRNAs are covalently closed lncRNAs whose participation in 
neurodegeneration has been started to be elucidated. Eukaryotic circRNAs have been shown to 
have dynamic expression patterns in various physiological conditions and developmental stages. 
CircRNAs potentially can regulate the cellular response to stress through various mechanisms. 
For example, circRNAs can regulate the function of miRNAs involved in hemostasis and stress 
pathways (Fischer & Leung, 2017). Interestingly, the study of circRNAs expression profile in 
Arabidopsis in response to heat stress showed a massive alteration in the expression of 
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circRNAs, the number of circularized exons, and alternative circularization events (Pan et al, 
2018). A study of circRNAs in Parkinson’s disease showed that one dysregulated circRNA in 
this disease, named circSLC8A, potentially has a role in oxidative stress‐related Parkinsonism 
(Hanan et al, 2020).  
Previously, whole transcriptome RNA-seq (Illumina) of libraries prepared from ribosome-
depleted RNA from human spinal cord tissues was performed in our lab to investigate the 
alteration of circRNAs in sporadic ALS patients compared to matched controls (Campos-Melo, 
data not shown). In-silico analysis indicated that 25.7% of circRNAs were dysregulated in sALS 
patients compared to controls. Further bioinformatic analysis of these dysregulated circRNAs 
using CircInteractome revealed that some of the highly dysregulated circRNAs potentially have 
interactions with important RBPs involved in the RNA metabolism and in ALS pathogenesis. As 
the involvement of cytoskeletal defects in neurodegenerative disorders is becoming increasingly 
evident, I selected a group of candidate circRNAs encoded in genes of cytoskeletal proteins 
vimentin, annexin A1, and Dynamin.  
Vimentin is a developmental IF protein that is broadly expressed in embryos and is often later 
replaced by the other major classes of IFs in cells during differentiation.  Vascular endothelial 
cells and certain subpopulations of glial cells are the only cells in the healthy adult brain that still 
express vimentin. However, it has been reported that vimentin is re-expressed in both 
protoplasmic and fibrous astrocytes in the brain of Alzheimer’s disease patients (Levin et al, 
2009). Annexin A1 and dynamin 1 are cytoskeletal proteins that directly interact with actin 
which has been implicated in motor neuron degeneration in ALS (Alkam et al, 2017; D’Ambrosi 
et al, 2014; Gu et al, 2010; Hayes et al, 2004; Hensel & Claus, 2018; McGough et al, 1994). As 
some circRNAs regulate the expression and splicing of their linear cognate transcripts, studying 
the relationship between them could shed further light on the pathogenesis of neurodegeneration 
(Conn et al, 2017). 
In this study, I examined the subcellular localization of a group of dysregulated circRNAs in 
ALS including hsa_circVIM_011 and hsa_circVIM_005 (encoded by VIM gene), 
hsa_circANXA1_001 (encoded by ANXA1 gene), and hsa_circDNM1_004 (encoded by DNM1 
gene) in HEK293T cells in response to stress. I also examined the subcellular localization of 
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CDR1as, as a highly expressed circRNA in the mammalian nervous system, in stressed 
HEK293T cells. 
1.5 Hypothesis 
 Considering the preceding evidence, the hypothesis underlying this thesis is that: 
“Cellular stress affects the subcellular localization of circRNAs dysregulated in ALS” 
1.6 Specific aims 
Aim 1: To analyze the expression level of circRNAs in spinal cord tissue of ALS patients. 
Aim 2: To study the expression and subcellular localization of candidate circRNAs under 
cellular stress in vitro. 
Sub-aim 2.1: To compare the expression of circRNAs using FISH in HEK293T cells under 
stress and baseline condition. 
Sub-aim 2.2: To study the subcellular localization of candidate circRNAs using FISH/IF under 










Chapter 2  
2 Procedures and methodology 
2.1 circRNAs selection 
Previously in our lab, Dr. Danae Campos-Melo, a research associate in the lab, had evaluated the 
expression levels of circRNAs within ALS (n=6) and control (neurologically and 
neuropathologically normal; n = 4) lumbar spinal cord using whole transcriptome RNA-seq 
(Illumina) of libraries prepared from ribosome-depleted RNA. Using Partek Flow software, a 
pool of differentially expressed circRNAs was identified (data not showed). Among the top 100 
dysregulated circRNAs in ALS according to RNA-seq data, I selected a group of 4 circRNAs 
that showed a dysregulation in ALS ≥ 2.5 fold and whose host genes encoded for the cytoskeletal 
proteins: vimentin, annexin A1, and dynamin 1. Next, I used the CircInteractome database 
(circInteractom) to retrieve mature circRNA sequences and map RBP binding sites on the 
selected circRNAs. All these circRNAs are exonic and including multiple exons. Interestingly, 
all the candidate circRNAs which are expressed from cytoskeletal genes are multiple exonic and 
have multiple isoforms. Figure 2-1 shows all the circRNAs that are expressed from VIM gene as 
an example. Further in silico analysis using CircInteractome for the candidate circRNAs 
indicated that they potentially have multiple binding sites for the RBPs that are known to be 
involved in varying aspects of RNA metabolism within RNP granules. I also used Circbank 
database (circbank) to rename candidate circRNAs based on their host genes. Characteristics of 




Table 2-1: List of candidate circRNAs. 
CircBase Id CircBank Id Strand Position Length 
Gene 
Symbol 























2.2 Primer design 
Because the candidate circRNAs for this study are multiple exonic, they have sequence overlap 
with their linear RNA counterpart. There is thus a chance of linear RNA amplification when 
undertaking PCR reactions for circRNAs. To solve this problem, three different strategies have 
been suggested to date. The first strategy is to digest linear RNAs using the RNase R enzyme 
(discussed in more detail later in section 2.3).  The remaining two strategies employ divergent 
primers that either flank the back-splice junction (BSJ) or primers that bind to the BSJ, which is 
the unique sequence element of circRNAs. Divergent primers are “tail-to-tail”-oriented 
compared with the “convergent primers,” which are “head-to-head”-oriented. Of note, if 
“convergent primers” are located within circRNA-producing exons, they would detect both 
circular and linear RNAs (Figure 2-2).  
In the present study, I took advantage of all three strategies by designing divergent primers 
(Table 2-2) that bind to the BSJ of candidate circRNAs and by applying reverse-transcription and 
qPCR reaction on RNase R treated RNA samples. 
In order to check whether or not the primer pairs designed for circRNAs were unique, the 
specificity of primers was checked in the NCBI primer blast (NCBI). Using the NCBI primer 
blast, I did not observe any known sequences that would be detected by my primer sets. Also, to 
minimize potential dimerization and secondary structures of primers, I evaluated primer sets 
using the OligoAnalyzer tool (Integrated DNA Technologies, IDTDNA) (IDTDNA). The 
OligoAnalyzer tool is an analytical tool for determining the oligo sequences’ properties including 
length, GC content, and the Gibbs free energy (ΔG) values. ΔG values indicate the strength of 
the secondary structures such as dimers and hairpins. I checked ΔG values of self and hetero 
dimers as well as hairpins for every primer set; all were within the recommended range (for 





Figure 2-1: CircRNAs annotated from VIM gene. There are 24 circRNAs that have been 
annotated to be expressed from VIM gene. All this circRNAs are exonic including single and 
multiple exons. Black arrows show the candidate circRNAs, hsa_circVIM_005 and 




Figure 2-2: Schematic of the design of convergent and divergent primers. A) Convergent 
primers are able to amplify both linear RNA and circRNAs. B) Divergent primers are only able 
to amplify circRNAs. C) Divergent primers detecting BSJ are only able to amplify circRNAs. D) 
Convergent primers are shown as blue arrows and divergent primers are shown as purple arrows. 
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 Table 2-2: Oligonucleotides for real-time PCR amplification. 
Oligonucleotide Sequence 5' to 3' 
Amplicon 
size 
CDR1as forward primer AACTACCCAGTCTTCCATCAACTGGCT 
158 bp 





























TBP forward primer TGTGTCCACGGTGAATCTTG 
182 bp 
TBP reverse primer GTTCCTCGCTTTTTGCTCCT 
 
2.3 RNA extraction and RNase R exonuclease assay 
In order to minimize the amount of linear RNAs, I performed an RNase R exonuclease digest on 
all RNA samples. This enriches the ratio of circRNAs to total RNA in the samples which 
increases the chance of detection by primers designed for circRNAs. To optimize the RNase R 
exonuclease digest, I used RNA samples derived from HEK 293T cells. Total RNA from 
HEK293T cells was purified using TRIzol™ reagent (Life Technologies Inc., Ambion, Carlsbad, 
CA, USA). To do this, cells were washed gently with cold 1X PBS then were lysed by adding 
400μl of TRIzol™ reagent and incubating for 5 minutes on ice. Next, 80μl of chloroform 
(ThermoFisher Scientific) was added to the lysate, gently mixed, and incubated for 2 minutes at 
room temperature and centrifuged for 15 minutes at 12,000g, 4°C. The aqueous phase was 
transferred into a fresh tube, RNA was precipitated by adding 200μl of isopropanol, incubating 
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for 10 minutes at room temperature, and centrifuging for 10 minutes at 12,000g, 4°C. 400μl 75% 
ethanol was used for washing the pelleted RNA and after centrifuging for 5 minutes at 7,500g, 
4°C the RNA pellet was air dried. Finally, the pellet was resuspended in 20μl UltraPure RNAse-
free distilled water (Invitrogen, ThermoFisher Scientific) and incubated for 15 minutes at 60°C. 
RNA concentration and purity were measured using spectrophotometry (Nanodrop, 
ThermoFisher Scientific, Burlington, ON, Canada). To determine the optimal conditions for 
digestion of linear RNA with RNase R, I used different units of RNase R (from 2 to 20 units). 
The digestion of linear RNAs were optimized using 15 unit of RNase R. Based on this 
optimization, I performed RNase R digestion by incubating 3-5 µg of RNA from cells or 
previously extracted RNA from human lumbar spinal cord tissue with 15 U of RNase R 
(Epicentre Biotechnologies) at 37°C for 30 minutes (Suzuki et al, 2006). RNase R- treated RNA 
was subsequently column purified using the RNeasy Mini Kit (Qiagen Cat. # 74106).   
2.4 Reverse-transcription and real-time PCR 
Real-time PCR was conducted using the same ALS and control spinal cord RNA samples that 
were used for the original RNA-seq performed on human lumbar spinal cord tissue by Dr. Danae 
Campos-Melo. Reverse-transcription and real-time PCR had been standardized in RNase R-
treated RNA samples from HEK293T cells. In summary, 2 μg of RNase R- treated RNA from 
each sample was treated with DNase I (Amplification grade, ThermoFisher scientist) for 15 
minutes at room temperature to digest genomic DNA pulled down in the RNA purification. The 
reaction was ended by adding Ethylenediaminetetraacetic acid (EDTA) (Thermo Fisher 
Scientific) and incubating at 65°C for 10 minutes. The concentration of RNA samples then was 
quantified using spectrophotometry (Nanodrop, ThermoFisher Scientific, Burlington, ON, 
Canada) and 0.5 ug of each RNA sample was used for cDNA synthesis. Reverse transcription 
was performed using SuperScript VILO (Invitrogen) incubating at 25°C for 10 minutes, 
following by 42°C for 120 minutes, and 80°C for 15 minutes in a total volume of 20 μl. The 
product of reverse transcription was used immediately or stored at -80°C. 
Each real-time PCR reaction contained 0.5 μl of cDNA, 1 μM of each primer set, and 5 μl 
PowerUp SYBR Green PCR master mix (Thermo Fisher Scientific), in a total volume for each 
reaction of 10 μl. All real-time PCR assays were carried out using only three technical replicates 
for each sample because of the limitation in amount of RNA samples from control patients. 
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Relative quantification of gene transcription was performed using TBP (TATA box binding 
protein) as the reference gene. Real-time PCR was performed on a ViiA7 real-time PCR machine 
(Applied Biosystems). 
2.5 Data analysis of real-time PCR data 
In order to examine the relative expression of circRNAs using data that was produced by real-
time PCR, I took advantage of the 2^-∆∆Ct method (Livak & Schmittgen, 2001). The Ct (cycle 
threshold) is the number of cycles required for the fluorescent signal to exceeds background level 
(threshold). In a real-time PCR assay, a positive reaction is detected by accumulation of a 
fluorescent signal. QPCR was performed in triplicate for each sample, so I averaged three Cts 
per sample to obtain a Ct mean. Then to normalized gene expression to the reference gene, which 
is TBP in this study, I calculated delta Ct (∆Ct) for each sample by using the following formula:  
∆Ct = Ct mean (circRNA) – Ct mean (TBP) (2-1) 
In order to then calculate relative gene expression, I averaged the ∆Ct values of the control 
group to create a control ∆Ct which is named ∆Ct (control average) 
The ∆∆Ct values for each sample were then calculated as: 
∆∆Ct = ∆Ct (ALS) – ∆Ct (control average) (2-2) 
Finally, to examine the fold gene expression, I calculated 2 to the power of negative ∆∆Ct. The 
formula for this is as follows: 
Fold change expression = 2-∆∆Ct (2-3) 
I have used this process for determining fold change expression for every circRNA of interest for 
each ALS case. In order to determine the significance of any observed differences, I checked the 
normality of data by Shapiro-Wilk test, then an independent t-test or Mann–Whitney U test was 
applied using GraphPad Prism 9.0.0 (GraphPad Software, Inc., San Diego, CA, USA). Data are 
represented as mean fold change of ALS samples (n=6) ± SEM. In these statistical tests the mean 
fold change values of ALS samples for every candidate circRNAs were compared to 1 as a mean 
fold change for control samples. A p-value ≤ of 0.05 was considered statistically significant.  
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2.6 Cell culture and stress condition 
Human embryonic kidney (HEK293T) cells were cultured at 37°C and 5% CO2 in Dulbecco’s 
modified eagle medium (DMEM; ThermoFisher) supplemented with 10% fetal bovine serum 
(FBS; ThermoFisher) and 0.5% penicillin-streptomycin antibiotic (ThermoFisher). 24 hours 
before each experiment 600,000 cells per well were seeded in a 6-well plate on a 22 x 22 mm 
coverslip coated with attachment factor (Cascade Biologics Attachment factor, Gibco). Then, 
cells were exposed to osmotic stress using 400 mM D-sorbitol for 4 hours (in DMEM with 10% 
FBS). Post stress, cells were washed once with 1X PBS and then fixed in a 4% 
paraformaldehyde-1X PBS solution for 10 minutes.  
2.7 Expression and localization analyses with fluorescent in situ 
hybridization (FISH) 
Fluorescent in situ hybridization (FISH) with tyramine signal amplification was used to 
characterize the expression pattern and localization of the circRNAs in stressed HEK293T cells 
compared with non-stressed cells. LNA double DIG-labeled 48-mers probes (Qiagen, USA) 




Table 2-3: Oligonucleotides for fluorescence in situ hybridization. 
Oligonucleotide Sequence 5' to 3' 
Hybridization 
temperature (°C) 
CDR1as GAAACTAGAGATGGACAGGATGTTGAC 62 
hsa_circVIM_005 AATCTTTGGAAAAACTCTCCTCTGCCACTCTC 62 
hsa_circVIM_011 GAAACTAGAGATGGACAGGATGTTGAC 62 
hsa_circANXA1_001 CATGAACAAAGTTCTGGACCTGGAG 62 
hsa_circDNM1_004 GCACTAAGGAGCAGGCCAGCGCAC 62 
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In summary, fixed cells were permeabilized using 0.2% Triton X-100 in 1X PBS solution for 10 
minutes. Then, cells were incubated with pre-hybridization buffer (3% BSA in 4X SSC) in a 
humid chamber for 20 minutes at 22–25 °C below the predicted Tm value of each LNA 
oligonucleotide probe (hybridization temperature, TH). Probes were denatured at 90 °C for 5 
minutes and quickly moved to ice before they were diluted with pre-warmed hybridization buffer 
(20X SSC, 25% dextran sulfate, and DEPC-treated water). Coverslips were then incubated in 
100-300 µl of the diluted probe and hybridized for 1 hour at TH. After hybridization, coverslips 
were washed three times, for five minutes each, in washing buffer I (20X SSC, 0.1% Tween-20 
and DEPC-treated water) with agitation at 5 °C higher than TH. Then, three washes were done in 
washing buffer II and buffer III (20X SSC, DEPC-treated water) for 5 minutes each at TH. and 
one wash with 1X PBS for 5 minutes at room temperature. Coverslips were then incubated with 
freshly made hydrogen peroxide solution (3% (vol/vol) H2O2/1× PBS) for 20 minutes at room 
temperature to quench endogenous peroxidase activity before applying HRP-conjugated 
antibodies. Following three washes with TN buffer (1 M Tris-HCl pH 7.5, 1.5 M NaCl in DEPC-
treated water), coverslips were incubated in TNB blocking buffer (0.5% (wt/vol) blocking 
reagent /TN buffer) for 30 minutes at room temperature. Anti-DIG/HRP secondary antibody 
(Roche, Indianapolis, IN, USA) diluted 1:100 in blocking solution was applied on cells for 30 
minutes at room temperature. Cells were then washed three times with TNT buffer (0.5% 
(vol/vol) Triton X-100) /TN buffer) and incubated with Tyramide Signal Amplification tagged 
with a Cyanine 3 fluorophore (TSA Cy3; 1:50, PerkinElmer, Waltham, MA, USA) for 10 
minutes at room temperature. Coverslips were then washed three times for 5 minutes each with 
TNT buffer and one time with 1X PBS. Nuclear staining was performed using 4′,6-diamidino-2-
phenylindole (DAPI, Abcam, #ab228549). DAPI staining solution (0.05 mM DAPI solution in 
0.2% BSA/1×PBS) was used on coverslips for 5 minutes, and coverslips were then washed three 
times (5 minutes each) with 1X PBS and left to dry overnight. Coverslips were mounted to 
frosted glass microscope slides using fluorescent mounting media (Dako Canada Inc., 
Burlington, Ontario). All the steps after adding TSA Cy3 were performed in the dark. 
2.8  Immunofluorescence 
In order to observe whether circRNAs colocalize with RNP granule markers under stress, 
immunofluorescence was performed following FISH and before nuclear staining. Coverslips 
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were incubated with the blocking solution (4% BSA in 1X PBS; Fisher Scientific Company, 
Ottawa, Ontario) for 1 hour at room temperature to reduce non-specific antibody interactions. 
Each primary antibody was diluted in BSA solution (2% BSA in 1X PBS),  at the titers specified 
in Table 2-4 and coverslips were incubated overnight at 4°C. Coverslips were then washed three 
times with 1X PBS and incubated for 1 hour at room temperature with secondary AlexaFluor 
antibodies (Life Technologies) diluted in BSA solution (2% BSA in 1X PBS), as specified in 
Table 2-5.  Nuclear staining and mounting were performed as described in the previous section.  
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Table 2-4: List of primary antibodies used in this study. 
Antibody target Species Dilution Company (catalog #) 
TIA-1 Goat 1:100 Santa Cruz (sc-1751) 
Dcp-1 Mouse 1:250 Abnova (H00055802-A01) 
Staufen Rabbit 1:250 Millipore (AB5781MI) 
Pspc1 
Mouse 1:250 Sigma (SAB4200503) 
Rabbit 1:250 Abcam (ab10421238) 
NONO Mouse 1:250 BD Biosciences (611279) 
FUS Rabbit 1:250 Protein Tech (11570-1-AP) 





Table 2-5: List of secondary antibodies used in this study. 
Antibody target Species Dilution 
Catalog # from Life 
Technologies 
anti-goat Alexa 488 Donkey 1:1000  A-11055 
anti-rabbit Alexa 488 Goat 1:1000  A-11008 
anti-mouse Alexa 488 Goat 1:1000  A-11029 
anti-goat Alexa 555 Donkey 1:1000  A-21432 
anti-mouse Alexa 555 Rabbit 1:1000  A-27028 




2.9 Confocal microscopy and image processing 
Following FISH and IF, stressed and non-stressed cells were imaged using a laser scanning 
multi-photon confocal microscope (Leica TSC SP8, Germany) with a 63×/1.40 oil objective. 
Images were acquired using 488 nm (green channel) and 552 nm (red channel) laser lines for 
markers of RNP granules and circRNAs, respectively. The DAPI-stained nucleus was visualized 
using a 405 nm (blue channel) laser line. 
I also acquired sequential z-sections of stained samples and used these to reconstruct a three-
dimensional (3-D) image volume on which overlapping regions were determined by 
colocalization visualized by LASX (Leica Application Suite X (LAS X) and quantified by Imaris 
(Bitplane, Inc., Zürich, Switzerland) software. 
Before performing quantification of colocalization, a threshold for brightness intensity was 
defined for every channel in the images. In digital image processing, thresholding is a type of 
image segmentation that separates object pixels from background pixels to make the image 
easier to analyze. The threshold in this system is the minimum intensity of the color channel that 
will be calculated for the colocalization quantification. This adjustment of brightness intensity 
threshold is required for colocalization analysis to identify positive pixels that are relatively 
unaffected by the method of image acquisition and fluorophore brightness, and the level of 
molecule expression.  
In Imaris software, I first adjusted the threshold to identify the brightest 2% of pixels for each red 
and green channel to calculate circRNA and RNP granule marker colocalization statistics for the 
3-D volume. For this, I used the strategy previously described by Hutcheon et al (Hutcheon et al, 
2000) and also discussed in two other studies (Holmes et al, 2006; Hutcheon et al, 2004). In this 
method threshold is adjusted based on a fixed percentage of the brightest pixels in a channel. 
After adjusting thresholds for each channel, the colocalized pixels which are indicated in white 
was built for further quantifications. Colocalization quantification was acquired from 3-5 z-series 
images captured for the candidate circRNA and RNP granule markers. 
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2.10 Spot counting and analysis 
The expression analysis of two circRNAs (hsa_circVIM_011 and hsa_circANXA1_001) whose 
transcripts were able to be detected as a single spot was performed by quantifying the number of 
circRNA spots per cell obtained from confocal microscope images.  Other circRNAs showed 
signal accumulation (i.e., several spots located within small regions that could not be resolved by 
the microscope because of limitation in resolution) and for this reason they could not be 
quantified. For spot quantification, I automatically counted the number of fluorescent spots for 
an average of 20 cells per slide across six slides of both stressed and unstressed HEK293T cells 
using FIJI/ImageJ software, as previously described (Lee et al, 2016; Schindelin et al, 2012). The 
normality of data was checked by the Shapiro-Wilk test, then an independent t-test or Mann–
Whitney U test was applied to assess the differences in the expression levels of circRNAs 
between stress and baseline condition (mean ± SEM). All statistical analyses were performed by 




Chapter 3  
3 Results 
3.1 Experimental set 1 – Real-time PCR shows no significant 
differential expression of candidate circRNAs in the spinal 
cord tissue of ALS versus control patients 
3.1.1 Introduction 
In recent years, large-scale transcriptome sequencing has provided the opportunity of studying 
the potential alteration of coding and non-coding RNAs in various diseases including 
neurodegenerative disorders. Emerging evidence has implicated alterations of circRNAs 
expression in a wide range of complicated diseases including cancers and neurodegenerative 
disorders. Previously, the alteration of circRNAs in blood samples of sporadic ALS patients has 
been reported (Dolinar et al, 2019). Moreover, circRNAs expression was dysregulated in murine 
embryonic stem cell-derived motor neurons containing ALS-related mutations in FUS (Errichelli 
et al, 2017). Our lab had undertaken whole transcriptome RNA-seq of ribosome-depleted RNA 
from human lumbar spinal cord tissues and observed an alteration of circRNAs expression in 
sporadic ALS patients compared to matched controls (Campos-Melo, unpublished data). Using 
Partek Flow software a pool of differentially expressed circRNAs was identified. This data 
showed that 25.7% of circRNAs were dysregulated in in the human spinal cord of sALS patients 
versus control patients. Among the top 100 dysregulated circRNAs in ALS according to this 
RNA-seq data, I selected 4 circRNAs that were expressed from host genes encoding cytoskeletal 
proteins and were upregulated by ≥ 2.5 fold change. Then I used real-time PCR to examine the 






3.1.2.1 Real-time PCR showed no significant differences in the 
expression of candidate circRNAs between ALS and control patients’ 
samples 
As described, for the selective amplification of circRNAs I designed specific divergent primers 
detecting the BSJ of circRNAs and then treated RNA samples with the RNase R enzyme to 
decrease the amount of linear RNAs. Melting curve plots showed one single peak for every set of 
primers designed for circRNAs of interest except for circANXA1-001 (Figure 3-1). An analysis 
of the mature sequence of circANXA1-001 showed an A-rich sequence (ARS) in the BSJ, which 
made primer designing problematic. I used two different primer sets for the BSJ of circANXA1-
001. Although optimization experiments using RNA samples from HEK293T cells showed 
normal amplification and melting curve plots (Figure 3-2), this result could not be reproduced in 
RNA samples from ALS and control patients. 
When I next analyzed the 10 µl of the sample from qPCR on 1.5% agarose gel, I observed more 
than one band for circRNAs hsa_circDNM1_004 and hsa_circVIM_005 (Figure 3-3). Moreover, 
the qPCR sample from the primer set for hsa_circANXA1_001 did not yield any band on the 
agarose gel. It is possible that because of the difficulty in primers’ design we could not detect 
this circRNA. Another possibility is that hsa_circANXA1_001 is present at very low levels in 
human spinal cord tissue samples. One approach that can be applied in future studies would be to 
increase the amount of cDNA per well in real-time PCR.  However, due to limitations imposed 
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Figure 3-1: Amplification and melting curve plots for target circRNAs and TBP gene 
amplified from ALS and control samples.  Amplification and melting curve plots showed 
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optimal curves for all the candidate circRNAs except for hsa_circANXA1_001. 
Hsa_circANXA1_001 showed suboptimal amplification and melting curve plots which indicated 
a suboptimal amplification efficiency for the primer set designed for this circRNA. Left plots are 
showing amplification plots (Y-axis: normalized fluorescent signal (ΔRn), X-axis: cycle 
number). Right plots are showing melting curves (Y-axis: difference in fluorescence/difference 





Figure 3-2: Amplification and melting curve plots for hsa_circANXA1_001 primers used 
on cDNA from HEK293T. Left plot is showing amplification plot (Y-axis: normalized 
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fluorescent signal (ΔRn), X-axis: cycle number). Right plot is showing melting curve (Y-axis: 







Figure 3-3: Agarose gel electrophoresis of qPCR products from ALS and control samples. 
A) CDR1as. B) Hsa_circDNM1_004. C) Hsa_circVIM_005. D) Hsa_circVIM_011. E) 
Hsa_circANXA1_001. F) TBP. There is more than one band for circRNAs hsa_circDNM1_004 
(B) and hsa_circVIM_005 (C) on the gel. We did not observe a PCR product from the primer set 










 In the present study, I did not observe an alteration in the expression levels between ALS and 
control cases for the candidate circRNAs chosen for this analysis similar to RNA-seq data 
(Figure 3-4). The raw data for real-time PCR for candidate circRNAs are presented in Table 3-1 





Figure 3-4: Real-time PCR did not show significant differences in the expression of 
candidate circRNAs between ALS and control patients’ samples.  Expression levels were 
normalized to TBP as a reference gene. Each dot represents circRNA fold change (ALS/Control) 
obtained from one patient sample and the bar represents mean (n=6) fold-change (2^-ΔΔCT) ± 
SEM. The significance of data was determined using Student’s t-test (for hsa_circVIM_005 and 
hsa_circVIM_011) and Mann–Whitney U test (for CDR1as and hsa_circDNM1_004). A p>0.05 




Table 3-1: Raw data for real-time PCR of CDR1as in control and ALS samples. 
Sample CDR1as Average Ct TBP Average Ct ∆Ct ∆∆Ct 2^-∆∆Ct 
Control 1 14.7134 25.2873 -10.57   
Control 2 14.7727 25.0598 -10.29   
Control 3 14.9439 25.9463 -11.00   
Control 4 13.9811 23.9968 -10.02   
ALS 1 15.6796 26.0741 -10.39 0.08 0.95 
ALS 2 15.0174 26.4587 -11.44 -0.97 1.96 
ALS 3 15.2220 25.2300 -10.01 0.46 0.73 
ALS 4 14.1546 24.1884 -10.03 0.44 0.74 
ALS 5 14.6017 24.9281 -10.33 0.14 0.91 





Table 3-2: Raw data for real-time PCR of hsa_circVIM_005 in control and ALS samples ي 
 
Sample hsa_circVIM_005 Average Ct TBP Average Ct ∆Ct ∆∆Ct 2^-∆∆Ct 
Control 1 23.8487 25.2873 -1.44   
Control 2 21.1583 25.0598 -3.90   
Control 3 22.7733 25.9463 -3.17   
Control 4 21.5996 23.9968 -2.40   
ALS 1 24.3404 26.0741 -1.73 1.00 0.50 
ALS 2 23.2341 26.4587 -3.22 -0.49 1.41 
ALS 3 22.0718 25.2300 -3.16 -0.43 1.35 
ALS 4 21.7383 24.1884 -2.45 0.28 0.82 
ALS 5 23.1101 24.9281 -1.82 0.91 0.53 
ALS 6 21.6253 23.9553 -2.33 0.40 0.76 
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Table 3-3: Raw data for real-time PCR of hsa_circVIM_011 in control and ALS samples. 
Sample hsa_circVIM_011 Average Ct TBP Average Ct ∆Ct ∆∆Ct 2^-∆∆Ct 
Control 1 24.8482 25.2873 -0.44   
Control 2 22.8115 25.0598 -2.25   
Control 3 25.0141 25.9463 -0.93   
Control 4 24.1103 23.9968 0.11   
ALS 1 25.4227 26.0741 -0.65 0.23 0.85 
ALS 2 23.7641 26.4587 -2.69 -1.81 3.52 
ALS 3 23.1774 25.2300 -2.05 -1.17 2.25 
ALS 4 23.4532 24.1884 -0.74 0.14 0.90 





Table 3-4: Raw data for real-time PCR of hsa_circDNM1_004 in control and ALS samples. 
Sample hsa_circDNM1_004 Average Ct TBP Average Ct ∆Ct ∆∆Ct 2^-∆∆Ct 
Control 1 23.0906 25.2873 -2.20   
Control 2 21.8764 25.0598 -3.18   
Control 3 23.1907 25.9463 -2.76   
Control 4 22.0078 23.9968 -1.99   
ALS 1 23.4062 26.0741 -2.67 -0.14 1.10 
ALS 2 23.7346 26.4587 -2.72 -0.19 1.14 
ALS 3 22.6201 25.2300 -2.61 -0.08 1.06 
ALS 4 20.8476 24.1884 -3.34 -0.81 1.75 
ALS 5 22.6127 24.9281 -2.32 0.21 0.86 





3.2 Experimental set 2 – dysregulation of candidate circRNAs’ 
expression in stressed HEK293T cells 
3.2.1 Introduction 
As discussed, cellular stress has been implicated in the pathogenesis of ALS. Several studies 
have examined the effect of cellular stress on the expression of non-coding RNAs. For example, 
oxidative stress has been shown to be associated with dysregulated expression of several 
lncRNAs (Bianchessi et al, 2015; Guo et al, 2019; Luo et al, 2019; Zhang et al, 2019). Besides, 
the participation of non-coding RNAs including both miRNAs and lncRNAs in the oxidative 
stress process have been recently revealed (Guo et al, 2017; Tang et al, 2015). Therefore, 
regulating the expression of non-coding RNAs can be a feasible route for the modulation of 
cellular stress response. In this study, I examined the expression of candidate circRNAs in 
stressed HEK293T cells compared to unstressed cells using FISH. 
3.2.2 Results 
3.2.2.1 circRNAs show an altered granule formation in stressed 
HEK293T cells compared with unstressed cells. 
FISH allows quantification of RNA transcript abundance through both the including 
quantification of fluorescent signal intensity and the number of fluorescent spots. In the present 
study, the expression analysis of the circRNA candidates was performed quantifying the number 
of circRNA spots per cell obtained from confocal microscope images. Candidate circRNAs were 
visualized by FISH, using a DIG-labeled back-splicing junction-spanning oligonucleotide.  For 
spot quantification, I used ImageJ (Fiji) software as previously described (Lee et al, 2016; 
Schindelin et al, 2012). This data showed that the number of fluorescent spots for circRNA 
hsa_circANXA1_001 and hsa_circVIM_011 significantly decreased in HEK293T cells in 
response to stress (Figure 3-5 a and b, respectively).  The spot quantification was not applicable 
for other candidate circRNAs using this method as they showed fluorescent signal accumulation 
that precluded the analysis of discrete spots. The comparison of the size of fluorescent spots for 
these two circRNAs in stressed versus unstressed cells did not showed any significant difference 







Figure 3-5: Quantification of circRNA hsa_circVIM_011 and hsa_circANXA1_001 by RNA 
FISH.  (A) The number of fluorescent spots was significantly decreased for circRNA 
hsa_circVIM_011 in HEK293T cells in response to osmotic stress. (B) The number of 
fluorescent spots was significantly decreased for circRNA hsa_circANXA1_001 in HEK293T 
cells in response to stress. Fluorescent spots in 20 cells per every sample slide (n=6) were 
automatically counted.  The bar represents the mean (n=6) average number of spots per cell 
(n=18) ± SEM. The significance of data was determined using a Student’s t-test (** p ≤ 0.01, 




3.3 Experimental set three: circRNAs colocalize with the 
markers for RNP granules in HEK293T cells under stress. 
3.3.1 Introduction. 
In fluorescence microscopy, colocalization analysis is used to determine whether two molecules 
colocalize with each other or with the same structures (for example, to determine whether a 
circRNA colocalize with an RNP granule). Of note, an overlap in fluorescence signals does not 
absolutely define colocalization. Every colocalization consists of two components: co-occurrence 
(the simple spatial overlap of two probes) and correlation (when two probes not only overlap but 
also co-distribute in proportion). Colocalization in fluorescence microscope images may be 
evaluated visually, quantitatively, and statistically (Dunn et al, 2011). 
Although modern fluorescence microscopy produces detailed three-dimensional (3D) datasets, 
colocalization analysis and region of interest (ROI) selection is most commonly performed two-
dimensionally (2D) using maximum intensity projections (MIP). However, these 2D projections 
exclude much of the available data. Furthermore, 2D ROI selections cannot adequately select 
complex 3D structures which may inadvertently lead to either the exclusion of relevant or the 
inclusion of irrelevant data points, consequently affecting the accuracy of the colocalization 
analysis. 
The most common method of determining colocalization using fluorescence microscopy is to 
show the image of two fluorophores in the red and green channels of an RGB two-dimensional 
(2-D) image and consider yellow pixels in the overlay channel as a colocalization. The selection 
of region of interest (ROI) in 2-D excludes much of the available data because of inability in 
adequately selection of complex 3-D structures. Moreover, 2-D colocalization might increase the 
probability of false positive colocalization. This is because the observation of the merged yellow 
pixels depends on the relative intensities of red and green fluorophores and when the intensity 
levels of fluorophores are similar, even they are in different location, results in the perception of 
colocalization because of the restricted ability of eyes to perceive and interpret colors. 
Fortunately, modern fluorescence microscopy provides a chance to acquire the z-stacks 
consisting of multiple 2-D images, which can be reconstructed to 3-D images using direct-
volume rendering.  (Bolte & Cordelières, 2006; Dunn et al, 2011).  
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These visual techniques are helpful to provide a spatial sense of colocalization and recognize the 
regions where molecules colocalize. However, the visual evaluation of colocalization is not able 
to determine the degree of colocalization and if this degree exceeds random coincidence 
(Pompey et al, 2013).  Therefore, in the present study, first I used a qualitative method to identify 
the colocalization between candidate circRNAs and markers of RNP granules. Then I quantified 
the observed colocalization. 
3.3.2 Results 
3.3.2.1 Visual evaluation in 2-D showed colocalization between 
circRNAs with markers of RNP granules 
Two-dimensional colocalization studies using single-molecule FISH for circRNAs and IF for 
RNP granules’ markers showed that three of the candidate circRNAs for this study colocalize 
with RNP granules’ markers.  
The analysis of colocalization of circRNAs with Staufen positive transport granules showed that 
CDR1as, hsa_circVIM_005 and hsa_circDNM1_004 colocalize in Staufen positive transport 
granules in stressed HEK293T cells (Figure 3-36, Figure 3-7, and Figure 3-8, respectively). 
Hsa_circVIM_011 and hsa_circANXA1_001 did not show colocalization with this marker of 
transport granules (Figure 3-9 and Figure 3-10, respectively). 
A study of colocalization of circRNAs with TIA-1 positive transport granules showed that  
CDR1as, hsa_circVIM_005, and hsa_circDNM1_004 colocalize in TIA-1 positive stress 
granules in stressed HEK293T cells (Figure 3-11, Figure 3-12, and Figure 3-13, respectively). 
Hsa_circVIM_011 and hsa_circANXA1_001 did not show colocalization with this marker of 
stress granules (Figure 3-14 and Figure 3-15, respectively). 
The study of colocalization of circRNAs with Dcp1 positive P-bodies showed that CDR1as, 
hsa_circVIM_005, hsa_circDNM1_004, and hsa_circVIM_011 colocalize with Dcp1 positive P-
bodies in stressed HEK293T cells (Figure 3-16, Figure 3-17, Figure 3-18, and Figure 3-19, 
respectively). However, hsa_circANXA1_001 did not show any colocalization with the marker 
of P-bodies (Figure 3-20). 
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A study of colocalization of circRNAs with PSPC1 showed that hsa_circDNM1_004 and 
colocalize with PSPC1fibril structures (Figure 3-21). CDR1as, hsa_circVIM_005, 
hsa_circVIM_011, and hsa_circANXA1_001 did not show any colocalization with PSPC1 fibril 
structures (Figure 3-22, Figure 3-23, Figure 3-24, and Figure 3-25, respectively).  
I also studied the colocalization of a random selection of candidate circRNAs with NONO as 
another marker for paraspeckles. The result showed that hsa_circDNM1_004 and 
hsa_circVIM_011 colocalize with NONO in stressed HEK293T cells (Figure 3-26 and Figure 
























    
 
 
Figure 3-6: CDR1as colocalizes with Staufen positive stress granules under osmotic stress.  
The upper panel shows unstressed HEK293T cells, and the lower panel shows stressed 






















    
     
Figure 3-7: Hsa_circVIM_005 colocalizes with Staufen positive transport granules under 
osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel shows 







Figure 3-8: Hsa_circDNM1_004 colocalizes with Staufen positive transport granules under 
osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel shows 
stressed HEK293T cells (400 mM sorbitol for 4 hours). Scale bars represent 10 μm. 
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Figure 3-9: Hsa_circVIM_011 does not colocalize with Staufen positive transport granules 
under osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel 






















    
 
Figure 3-10: Hsa_circANXA1_001 does not colocalize with Staufen positive transport 
granules under osmotic stress.  The upper panel shows unstressed HEK293T cells, and the 























    
 
Figure 3-11: CDR1as colocalizes with TIA-1 positive stress granules under osmotic stress.  
The upper panel shows unstressed HEK293T cells, and the lower panel shows stressed 





Figure 3-12: Hsa_circVIM_005 colocalizes with TIA-1 positive stress granules under 
osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel shows 
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Figure 3-13:  Hsa_circDNM1_004 colocalizes with TIA-1 positive stress granules under 
osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel shows 

























    
 
Figure 3-14: Hsa_circVIM_011 does not colocalize with TIA-1 positive stress granules 
under osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel 






















    
 
Figure 3-15: Hsa_circANXA1_001 does not colocalize with TIA-1 positive stress granules 
under osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel 






















    
 
Figure 3-16: CDR1as colocalizes with Dcp1 positive P-bodies under osmotic stress.  The 
upper panel shows unstressed HEK293T cells, and the lower panel shows stressed HEK293T 





Figure 3-17: Hsa_circVIM_005 colocalizes with Dcp1 positive P-bodies under osmotic 
stress.  The upper panel shows unstressed HEK293T cells, and the lower panel shows stressed 
HEK293T cells (400 mM sorbitol for 4 hours). Scale bars represent 10 μm. 
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Figure 3-18: Hsa_circDNM1_004 colocalizes with Dcp1 positive P-bodies under osmotic 
stress.  The upper panel shows unstressed HEK293T cells, and the lower panel shows stressed 























    
 
Figure 3-19: Hsa_circVIM_011 colocalizes with Dcp1 positive P-bodies under osmotic 
stress.  The upper panel shows unstressed HEK293T cells, and the lower panel shows stressed 






















    
 
Figure 3-20: Hsa_circANXA1_001 does not colocalize with Dcp1 positive P-bodies under 
osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel shows 






















    
 
Figure 3-21: Hsa_circDNM1_004 colocalizes with PSPC1 cytoplasmic fibrillar structures 
under osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel 








Figure 3-22: CDR1as does not colocalize with PSPC1 cytoplasmic fibrillar structures under 
osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel shows 
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Figure 3-23: Hsa_circVIM_005 does not colocalizes with PSPC1 cytoplasmic fibrillar 
structures under osmotic stress.  The upper panel shows unstressed HEK293T cells, and the 























    
 
Figure 3-24: Hsa_circVIM_011 does not colocalize with PSPC1 cytoplasmic fibrillar 
structures under osmotic stress.  The upper panel shows unstressed HEK293T cells, and the 























    
 
Figure 3-25: Hsa_circANXA1_001 does not colocalize with PSPC1 cytoplasmic fibrillar 
structures under osmotic stress.  The upper panel shows unstressed HEK293T cells, and the 























    
 
Figure 3-26: Hsa_circDNM1_004 colocalizes with NONO positive cytoplasmic structures 
under osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel 






















    
 
Figure 3-27: Hsa_circVIM_011 colocalizes with NONO positive cytoplasmic structures 
under osmotic stress.  The upper panel shows unstressed HEK293T cells, and the lower panel 






















    
 
Figure 3-28: Hsa_circANXA1_001 does not colocalize with NONO positive paraspeckles in 
the nucleus of HEK293T cells under osmotic stress. The upper panel shows unstressed 
HEK293T cells, and the lower panel shows stressed HEK293T cells (400 mM sorbitol for 4 




3.3.2.2 3-D analysis showed colocalization between circRNAs with 
markers of RNP granules  
In the previous section, I showed colocalization of circRNAs with specific markers of RNP 
granules using 2-D merge images following FISH and IF. But that visual evaluation did not 
define the degree of colocalization. Therefore, I used z-series imaging to reconstruct 3-D images 
using LASX software. I also used Imaris software to acquire a colocalization channel which is 
indicated by white colour. Three-dimensional colocalization studies for circRNAs and RNP 
granule markers could not confirm all the colocalizations which were observed in 2-D images. 
As previously discussed, 2-D imaging is not as accurate as 3-D imaging because of limitation of 
2-D imaging in distinguishing a true colocalization from the overlapping of signals with similar 
intensity which are not colocalized in the same position. 
3-D imaging showed that CDR1as, hsa_circVIM_005, and hsa_circDNM1_004 circRNAs 
colocalize with Staufen, TIA-1, and Dcp1 as markers of transport granules, stress granules, and 
P-bodies, respectively. CircRNA hsa_circDNM1_004 also colocalized with PSPC1 and NONO 
which are markers of paraspeckles. Figure 3-29 to Figure 3-32 are showing examples of 3-D 
images for candidate circRNAs acquired by LASX software (left panel) and Imaris software 
(middle panel). However, 3-D imaging using LAS X software could not confirm colocalization 
observed for hsa_circVIM_011 and Dcp1 and NONO in 2-D images (Figure 3-33 and Figure 
3-34, respectively). 
The qualitative indication of the degree of colocalizations is represented graphically in 
scatterplots (also called cytofluorogram) (Demandolx & Davoust, 1996). In these scatterplots, 
the intensity of the red color is plotted against the intensity of the green color for each voxel. 
Voxel is a basic picture element for composing 3D images. Every voxel in the image is plotted in 
the scatterplots based on its intensity level from each channel. This diagram reflects the 
distribution of pairs of voxel intensities occurring in the two selected channels. In this analysis, 
red intensity is shown on the x-axis and represents circRNA and green intensity is shown on the 
y-axis and represents RNP granule’s marker. The density (frequency) of the voxels is visualized 
as a heat map-like coloring in the scatterplot. The highest number of voxels are visualized by red 
points and the lowest number of voxels are visualized by purple points. The hatched region with 
bolded yellow lines is indicating established thresholds. The bolded yellow lines define the 
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intensity threshold for the red and green channels. Only voxels with an intensity value above the 
established threshold can be considered for the colocalization analysis. Analyzing scatterplots 
showed that the points of any of the scatterplots did not cluster around a straight line, whose 
slope reflects the ratio of the fluorescence of the two colors. The pattern of the distribution of 
points in the scatterplots showed only a low number of voxels from each channel correlate to 
each other which means partial colocalization for every pair of circRNAs and marker of RNP 










Figure 3-29: CircRNAs partially colocalize with Staufen positive transport granules in 
HEK293T cells under osmotic stress.  Panel (A), (B), and (C) are showing colocalization of 
CDR1as, hsa_circVIM_005, and hsa_circDNM1_004 with Staufen positive transport granules, 
respectively. In each panel, the left image is showing one example of 3-D images acquired by 




images acquired by Imaris software for every candidate circRNA which is indicating partial 
colocalization by white color. The right images are showing the intensity scatterplots. The 
hatched region with bolded yellow lines in the upper right quadrant defines the intensity 
threshold for the red and green channels. This region represents colocalized voxels. The pattern 
of the distribution of points and their color (red indicating the highest frequency of colocalized 
voxels; purple indicating the lowest frequency of colocalized voxels) in the scatterplots showed 
only a low number of voxels from each channel correlate to each other which means partial 
colocalization. All cells were imaged following stress (400 mM sorbitol for 4 hours, as 









Figure 3-30: CircRNAs colocalize with TIA-1 positive stress granules in HEK293T cells 
under osmotic stress.  Panel (A), (B), and (C) are showing colocalization of CDR1as, 
hsa_circVIM_005, and hsa_circDNM1_004 with TIA-1 positive stress granules, respectively. In 
each panel, the left image is showing one example of 3-D images acquired by LASX software 
for every candidate circRNA. The middle image is showing one example of 3-D images acquired 
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by Imaris software for every candidate circRNA which is indicating partial colocalization by 
white color. The right images are showing the intensity scatterplots. The hatched region with 
bolded yellow lines in the upper right quadrant defines the intensity threshold for the red and 
green channels. This region represents colocalized voxels. The pattern of the distribution of 
points and their color (red indicating the highest frequency of colocalized voxels; purple 
indicating the lowest frequency of colocalized voxels) in the scatterplots showed only a low 
number of voxels from each channel correlate to each other which means partial colocalization. 
All cells were imaged following stress (400 mM sorbitol for 4 hours, as previously described). 









Figure 3-31:  CircRNAs colocalize with Dcp1 positive P-bodies in HEK293T cells under 
osmotic stress.   Panel (A), (B), and (C) are showing colocalization of CDR1as, 
hsa_circVIM_005, and hsa_circDNM1_004 with Dcp1 positive P-bodies, respectively. In each 
panel, the left image is showing one example of 3-D images acquired by LASX software for 
every candidate circRNA. The middle image is showing one example of 3-D images acquired by 
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Imaris software for every candidate circRNA which is indicating partial colocalization by white 
color. The right images are showing the intensity scatterplots. The hatched region with bolded 
yellow lines in the upper right quadrant defines the intensity threshold for the red and green 
channels. This region represents colocalized voxels. The pattern of the distribution of points and 
their color (red indicating the highest frequency of colocalized voxels; purple indicating the 
lowest frequency of colocalized voxels) in the scatterplots showed only a low number of voxels 
from each channel correlate to each other which means partial colocalization. All cells were 
imaged following stress (400 mM sorbitol for 4 hours, as previously described). Scale bars 







Figure 3-32: Hsa_circDNM1_004 CircRNA colocalizes with PSPC1 and NONO in 
HEK293T cells under osmotic stress.  Panel (A) and (B) are showing colocalization of 
hsa_circDNM1_004 with PSPC1 and NONO as the markers for nuclear paraspeckles, 
respectively. However, both markers showed nuclear and cytoplasmic distribution in response to 
stress. PSPC1 makes fibrillar structures and NONO makes granular structures in the cytoplasm 
which show partial colocalization with hsa_circDNM1_004. In each panel, the left image is 
showing one example of 3-D images acquired by LASX software for every candidate circRNA. 
The middle image is showing one example of 3-D images acquired by Imaris software for every 
candidate circRNA which is indicating partial colocalization by white color. The right images are 
showing the intensity scatterplots. The hatched region with bolded yellow lines in the upper right 
quadrant defines the intensity threshold for the red and green channels. This region represents 
colocalized voxels. The pattern of the distribution of points and their color (red indicating the 
highest frequency of colocalized voxels; purple indicating the lowest frequency of colocalized 





each other which means partial colocalization. All cells were imaged following stress (400 mM 




   
   
Figure 3-33: Hsa_circVIM_011 CircRNA does not colocalize with Dcp1 positive P-bodies in 
HEK293T cells under osmotic stress.  In order to show this 3-D image in 2-D, I present 
different angel of the cells in separate images. Z-stack images were acquired using Leica TSC 
SP8 confocal microscope and 3-D image were rendered using LAS X software. The cells were 
imaged following stress (400 mM sorbitol for 4 hours, as previously described). Scale bar 







     
 
  
Figure 3-34: Hsa_circVIM_011 CircRNA does not colocalize with NONO positive 
cytoplasmic structures in HEK293T cells under osmotic stress.  In order to show this 3-D 
image in 2-D, I present different angel of the cells in separate images. Z-stack images were 
acquired using Leica TSC SP8 confocal microscope and 3-D image were rendered using LAS X 
software. The cells were imaged following stress (400 mM sorbitol for 4 hours, as previously 
described). Scale bar represents 10 μm. 
 






3.3.2.3 Quantitative and statistical evaluation of colocalization 
To quantify the level of colocalization observed visually, I used the “coloc option” in the Imaris 
software. I selected the intensity-based correlation method which is one of the quantitative 
approaches for colocalization analysis. 
To quantify the extent of circRNA colocalization with each individual marker of RNP granule, I 
used the statistics provided by Imaris for the colocalized channel. This statistic shows the 
percentage of circRNA volume that is colocalized with the marker of RNP granules. This value 
is calculated by dividing the total count of colocalized voxels by the total count of red channel 
voxels (representing circRNA) multiply by 100. In this statistic, only voxels with intensity above 
the established threshold were counted. This data showed that the distribution of circRNAs 
varies in different RNP granules. I also used this method to quantify the percentage volume of 
CDR1as colocalized with FUS and TDP-43 positive aggregates. The percentage of each 
circRNA volume which colocalized with each marker of RNP granules is presented in the bar 
chart classified based on circRNAs ( Figure 3-35).  
Different percentages of CDR1, hsa_circVIM_005, and hsa_circDNM1_004 volumes above 
established threshold colocalized with different markers of RNP granules. The highest 
percentage of CDR1as and hsa_circVIM_005 volume above threshold (13.26 ± 12.22 and 10.49 
± 6.45, respectively) colocalized with TIA-1 positive stress granules in HEK293T cells in 
response to osmotic stress (Figure 3-35 A and B, respectively). A large percentage (19.62 ± 8.75) 
of hsa_circDNM1_004 volumes above threshold colocalized with Dcp-1 positive P-bodies and 
only a small percentage (less than 10%) of hsa_circDNM1_004 volumes above threshold 
colocalized with PCPC1 fibrillar structure in HEK293T cells under osmotic stress (Figure 3-35 
C). Some of candidate circRNAs seems to also colocalize with marker of RNP granules in 
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Figure 3-35: Comparison of quantification of the percentage of circRNAs volume above 
established threshold colocalized with the marker of RNP granule in HEK293T cells under 
osmotic stress.  A) Different percentages of CDR1as volume above threshold colocalize with 
Staufen, TIA-1, and Dcp1. It seems CDR1as tends to colocalize more with TIA-1 positive stress 
granules than other RNP granules in HEK293T cells under stress. B) A larger percentage of 
hsa_circVIM_005 volume colocalize with TIA-1 positive stress granule than other markers of 
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RNP granules. C) A larger percentage of hsa_circDNM1_004 colocalize with Dcp1 positive P-
bodies than other RNP granules. Quantifications were performed on 3 to 5 z-series images. The 
bar represents mean (n=3-5) ± SD. 
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In order to determine whether the observed co-occurrence or correlation is just a random 
coincidence or a true colocalization, I used the Pearson's correlation coefficient (PCC) in ROI 
(region of interest) volume provided by channel statistics in coloc tool in Imaris software. PCC is 
a statistic for quantifying the degree of colocalization. Here PCC gives a measure of the co-
distribution of fluorescence signals for circRNAs and marker of RNP granules within an image. 
The formula for PCC in this study is given below: 
                                  
(3-1)  
 
Ri and Gi refer to the intensity values of the red and green channels, respectively, of pixel i, 
and R̄ and Ḡ refer to the mean intensities of the red and green channels, respectively, across the 
entire image. The PCC values range between 1 and -1. A value of 1 represents perfect 
correlation, 0 no colocalization, and -1 perfect inverse colocalization (Zhang et al, 2014). In the 
other words, PCC=1 is describing a perfectly linear relation between the intensities of two 
fluorophores, whereas PCC=-1 means the intensities of two fluorophores are related inversely. 
PCC= 0 indicates a total absence of structured relation between the intensities of two 
fluorophores. Mid-range PCC are more difficult to interpret but are a good trend for comparing 
the colocalization (Dunn et al, 2011).  
Analyzing PCC values in ROI volumes of every pair of candidates circRNA and marker of RNP 
granule showed mid-range values (between 0 and 1) not extreme values (1 and -1) which is 
indicating partial colocalization. This data also showed that the degree of colocalization of 
circRNAs in the same RNP granule differs from each other.  The PCC values in ROI volumes of 
every pair of circRNAs and RNP granule markers are shown in graphs A, B, and C of Figure 
3-36. The information in this graph shows that the distribution of selected circRNAs varies in a 
different type of candidate RNP granules. 
Altogether, this data showed that hsa_circDNM1_004 has a higher colocalization degree with all 
the candidate markers of RNP granules under stress conditions. This observation as well as 3-D 
colocalization analysis which showed partial colocalization for candidate circRNAs with the 
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marker of RNP granules under stress condition, might indicate the participation of these 
circRNAs in the biology of RNP granule.  
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Figure 3-36:  Comparison of the degree of colocalization between circRNAs and RNP 
granule markers in HEK293T cells under stress using PCC values in ROI volumes. A)  
Quantification of the degree of colocalization between CDR1as and Staufen, TIA-1, and Dcp1 
showed a higher Pearson coefficient for colocalized voxels for CDR1as with TIA-1 and Dcp1 
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than Staufen. B) Quantification of the degree of colocalization between hsa_circVIM_005 and 
Staufen, TIA-1, and Dcp1 showed a higher Pearson coefficient for colocalized voxels for 
hsa_circVIM_005 with TIA-1 and Dcp1 than Staufen. C) Quantification of the degree of 
colocalization between hsa_circDNM1_004 and Staufen, TIA-1, Dcp1, PSPC1, and NONO 
showed a higher Pearson coefficient for colocalized voxels for hsa_circDNM1_004 with TIA-1 





4 Discussion and conclusion 
4.1 Overexpression of circRNAs encoded by cytoskeletal genes 
in ALS may affect their host gene expression or function  
The observations of altered expression of both coding and non-coding RNAs in ALS has been 
taken to support the proposal that ALS is a disorder of RNA metabolism (Droppelmann et al, 
2014; Strong, 2010). Such evidence includes spinal cord mRNA profiling by microarray which 
demonstrated a differential gene expression in spinal cord tissues of ALS patients compared to 
controls (Dangond et al, 2004; Offen et al, 2009). More recently, RNA-Seq studies have also 
revealed differential gene expression in ALS versus controls (Brohawn et al, 2016; D’Erchia et 
al, 2017; Prudencio et al, 2015). Moreover, a previous study from our lab has reported a massive 
dysregulation in miRNA expression in ALS (Campos-Melo et al, 2013a).  
Previously, Dr. Danae Campos-Melo from our lab had conducted a whole transcriptome RNA-
seq on ribosomal RNA-depleted RNA samples from ALS and the control lumbar spinal cord 
(unpublished observations).  Using Partek Flow software, Dr Campos-Melo identified a pool of 
differentially expressed coding and non-coding RNAs in ALS that includes differentially 
expressed circRNAs. From this analysis, I selected a group of 4 circRNAs that were upregulated 
in ALS (≥ 2.5 fold change) and that are expressed from genes encoding cytoskeletal proteins: 
vimentin, annexin A1, and dynamin 1. Mature circRNA sequences and potential binding sites for 
RBPs were defined using the CircInteractome database (circInteractom). In silico analysis using 
this database for the candidate circRNAs indicated that they potentially have multiple binding 
sites for the RBPs that are known to be involved in varying aspects of RNA metabolism within 
RNP granules. 
It is of note that when using real-time PCR with specific divergent primers detecting the back-
splice junction of circRNAs on RNase R-depleted RNA from the same ALS and control samples, 
I did not reproduce the same results as RNA-seq with respect to the previously observed 
differential expression. Because RNA-seq quantifies individual sequence reads aligned to a 
reference sequence, it produces absolute rather than relative expression values which enable the 
detection of subtle changes in expression, down to 10%. This might explain the difference 
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between RNA-seq and real-time PCR. Moreover, multiple circRNAs can be processed from a 
single gene locus with different numbers of exons included through a process named alternative 
circularization (Zhang et al, 2014). Interestingly, all the candidate circRNAs which are expressed 
from cytoskeletal genes are multiple exonic and have multiple isoforms (for example, 26 
different circRNA isoforms have been detected to be expressed from the DNM1 gene).  
The observation of multiple bands on agarose gels for at least two of the candidate circRNA used 
in this study made me speculate about the detection of multiple circRNA isoforms.  However, 
the analysis of all the isoforms annotated for the candidate circRNAs did not show overlaps in 
junction sequences.  
In order to understand the observed overexpression of circRNAs from cytoskeletal genes in 
spinal cord tissue of ALS patients from RNA-seq data, it might be helpful to review the studies 
about the expression and function of circRNAs in the mammalian nervous system. CircRNAs are 
abundant, conserved, and dynamically expressed lncRNAs in the mammalian nervous system 
(Hanan et al, 2017; Rybak-Wolf et al, 2015). Interestingly, several genes that encode circRNAs 
are exclusively expressed in the central nervous system. circRNAs abundance is also remarkably 
higher in the brain than in other tissues (You et al, 2015). Generally, circRNAs are 
overexpressed during neuronal differentiation and this differential expression is often 
independent of their linear counterparts (Kristensen et al, 2018b). Age-related overexpression of 
circRNAs in brain tissues is found across different species suggesting their possible involvement 
in aging and age-related diseases in the central nervous system such as ALS. Interestingly, this 
age accumulation of circRNAs is not largely relevant to the mRNA expression of their host 
genes (Cai et al, 2019). In the mammalian brain, circRNAs can be expressed from approximately 
20% of protein-coding genes at the expense of their linear cognates. Thus, the production of 
circRNA could be an important regulator for mRNA synthesis in the central nervous system 
(Rybak-Wolf et al, 2015). Observed overexpression of circRNAs encoded by cytoskeletal genes 
might be a regulatory process for the expression of their host genes in response to cytoskeletal 
defects that occurred in ALS pathogenesis (Julien et al, 2005). 
It has been discussed that generally there is no simple correlation between expression levels of 
circRNAs with the expression of their linear counterparts (Salzman et al, 2013b). It has also been 
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reported that most of the discovered circRNAs contain complete exons and are expressing from 
protein coding host genes. In vitro experiments demonstrate that spliceosome and RNA 
polymerase II (RNA pol II) mediate circRNAs expression through the back-splicing process 
(Braun et al, 1996; Pasman et al, 1996). Typically, those exons that undergo back splicing cannot 
be alternatively spliced. circRNAs production can compete with pre-mRNA alternative splicing 
suggesting the role of circRNAs in the regulation of mRNA expression (Salzman et al, 2012). 
Ashwal-Fluss et al. conducted a comprehensive study of circRNA biogenesis and showed that 
linear splicing can strongly compete with circRNA biogenesis and reduce circRNA levels. Thus, 
linear splicing and circRNA biogenesis mutually regulate each other through competing for 
splice sites (Ashwal-Fluss et al, 2014). 
 
4.2 Downregulation of hsa_circVIM_011 and 
hsa_circANXA1_001 in HEK293T cells in response to 
osmotic stress 
Both unicellular organisms and cells in multicellular organisms constantly experience exposure 
to environmental challenges such as oxidative stress, nutrient supply deprivation, pH alteration, 
temperature changes, and imbalances in osmolarity. Stress exposure to cells modulates several 
cellular pathways to maximize cell survival through proper adaptation. The alteration of gene 
expression is an essential component of the response to stresses. Immediately after stress 
exposure, the transcriptional pattern of the cell changes remarkably. The type of genes which 
undergo alteration depends on the type of organisms or cells and the type of stress and its 
strength. Several of those stress-responsive genes are stress-essential genes that are required for 
adaption to specific stresses. Stress-induced genes encode the proteins that are responsible for 
almost all general cell features including RNA metabolism, metabolic adjustment, cell 
differentiation, cellular transport, and cytoskeletal organization (Auesukaree et al, 2009; Giaever 
et al, 2002; Ruiz‐Roig et al, 2010; Zapater et al, 2007). Moreover, a variety of lncRNAs that play 
key roles in normal physiological conditions have been shown to also participate in the stress 
responses (Valadkhan & Valencia-Hipólito, 2015).  
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There is substantial evidence implicating cellular stress in the pathogenesis of ALS (Barber & 
Shaw, 2010). Thus, I decided to examine the role of cellular stress on the expression and 
subcellular localization of candidate circRNAs which were upregulated in ALS patients 
compared to control patients. In the present study, I observed that the number of fluorescent 
spots of two candidate circRNAs, hsa_circVIM_011, and hsa_circANXA1_001, is decreased in 
HEK293T cells in response to osmotic stress (400 mM D-sorbitol). The comparison of the size 
of this spot in stressed and unstressed cells did not show any significant difference. This data 
might indicate the decrease in expression of these circRNAs. However, the fluorescence intensity 
of theses spots, as well as the total fluorescence per cell must be also quantified to have a precise 
examination of the circRNAs’ expression using FISH. If I consider this significant decrease in 
the number of fluorescent spots as an indicator of downregulation of these two candidate 
circRNAs under stress condition, this contradicts the overexpression of candidate circRNAs 
observed in ALS. To explain this, it should be mentioned that, although HEK293T cells have 
some neuronal characteristics, they are not neuronal cells, thus stress-induced circRNAs 
alterations in this cell line might be different from neuronal cells. Importantly, osmotic stress 
induced by sorbitol is not able to emulate exactly what is happening in spinal cord tissue in ALS 
(Hock et al, 2018) 
Hsa_circVIM_011, and hsa_circANXA1_001 are transcribed from genes that encode the 
cytoskeletal related proteins vimentin and annexin A1 that directly interact with actin whose 
participation in ALS has been discussed in some studies (Esue et al, 2006; Gerke & Moss, 1997; 
Hensel & Claus, 2018). 
Eukaryotic cells construct a dynamic filamentous network using cytoskeletal proteins that 
provide mechanical stability of the cells. Cytoskeletal proteins also participate in transport 
mechanisms and cell movement in the cytoplasm. They are also involved in controlling signaling 
pathways by providing a surface for signaling molecules (Janmey, 1998). Vimentin is a 
developmental IF protein that is highly conserved with a significant degree of sequence 
homology among species (Ferrari et al, 1986; Franke et al, 1979b; Satelli & Li, 2011). Vimentin 
is broadly expressed in embryos and is often later replaced by the other major classes of IFs in 
cells during differentiation. While vascular endothelial cells and certain subpopulations of glial 
cells are the only cells in the healthy adult brain that still express vimentin (Bignami et al, 1982; 
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Franke et al, 1979a; Izmiryan et al, 2009), vimentin is re-expressed in both protoplasmic and 
fibrous astrocytes in the brain of Alzheimer's disease patients (Levin et al, 2009).  Annexin A1 
(also known as annexin 1) is a Ca2+ and phospholipid-binding protein that belongs to the 
annexins protein multigene family which is evolutionary conserved. Annexin A1 binds to F-actin 
and is involved in the regulation of membrane-cytoskeleton dynamics. This protein also interacts 
with profilin which regulates actin polymerization through interaction with G-actin. Association 
of annexin A1 and profilin modifies actin polymerization (Alvarez-Martinez et al, 1997; Gerke 
& Moss, 1997).  
Cytoskeletal rearrangement is one of the essential coping mechanisms for cells for adaptation in 
response to osmotic stress (Cornet et al, 1993). It has been observed that hyperosmolarity 
increases the speed of polymerization of F-actin and induces remodeling of the actin 
cytoskeleton (Bustamante et al, 2003; Di Ciano et al, 2002; Yamamoto et al, 2006). The exact 
mechanisms by which the cytoskeleton plays roles in osmoregulation remains unclear 
(Eggermont, 2003). However, it has been suggested that the cytoskeleton may involve volume 
rearrangement, mechanical protection against excessive shrinkage, and signal transmission from 
molecules sensing hyperosmolarity to the molecules responding to it. Moreover, it has been 
shown that osmotic stress modulates cytoskeletal protein expression. Vimentin and annexin A1 
are among the cytoskeleton proteins and cytoskeleton-associated proteins that overexpress in 
response to osmotic stress in medullary renal cells named, thick ascending limb of Henle’s loop 
(TALH cells) (Dihazi et al, 2005). In conclusion, the potential downregulation of 
hsa_circVIM_011 and hsa_circANXA1_001 might be because of overexpression of vimentin 
and annexin A1 in the cells in response to stress as a strategy for preservation of cell structures in 
response to osmotic stress. Further studies of the expression and function of circRNAs from 
cytoskeletal genes may shed further light on the pathogenesis of ALS (Conn et al, 2017).  
4.3 Potential role of candidate circRNAs in RNP granule biology 
Ribonucleoprotein (RNP) granules are large membraneless RNA–protein assemblies involved in 
many aspects of RNA metabolism. There are a variety of RNP granules in both the nucleus and 
cytoplasm of eukaryotic cells. An example of nucleic RNP granules is the paraspeckle. Transport 
(neuronal) granules, SGs, and P-bodies are described as cytoplasmic RNP granules. The 
formation of RNP granules requires protein-protein, RNA–RNA, and protein-RNA interactions. 
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Both coding and non-coding RNAs has been discovered in RNP granules with an essential role 
in the formation of these kinds of assemblies. For example, NEAT1 lncRNA is an essential 
component for paraspeckles assemblies in the nucleus which provides a scaffold for assemblies 
of other proteins and RBPs (Chen & Carmichael, 2009; Clemson et al, 2009; Sunwoo et al, 
2009). SGs, P-bodies, and transport granules also contain a combination of proteins, RBPs and 
nontranslating mRNAs. Although the presence of non-coding RNAs has been reported in RNP 
granules, no study has examined the presence of circRNAs in this kind of membraneless 
organelles. 
Here, I showed that three of the candidate circRNAs, CDR1as, hsa_circVIM_005, and 
hsa_circDNM1_004, colocalize with the markers of RNP granules: Staufen (a marker of 
transport granules), TIA-1 (a marker of SGs), and Dcp1 (a marker of P-bodies). I also observed 
hsa_circDNM1_004 colocalizes with PSPC1 and NONO, two important paraspeckles proteins. 
Quantification of the Pearson's correlation coefficients between candidate circRNAs and marker 
of RNP granules using Imaris software support the observation of partial colocalization between 
these components in that not all observed circRNAs were found to be associated with RNP 
granules.  I hypothesize that circRNAs may play role in the RNP granule formation by providing 
a scaffold for the interaction of other components of RNP granules. 
In support of this hypothesis, several studies have demonstrated that specific lncRNAs can act as 
essential architectural scaffolds for the construction of RNP granules in a variety of eukaryotes, 
including humans, mice, Drosophila, and yeast (Chujo & Hirose, 2017; Chujo et al, 2017; 
Yamazaki & Hirose, 2015). As mentioned before, NEAT1 lncRNA is an essential scaffold for 
paraspeckles proteins (Chen & Carmichael, 2009; Clemson et al, 2009; Sunwoo et al, 2009). In 
primates, highly repetitive satellite III (HSATIII) lncRNAs induce the formation of nuclear stress 
bodies (nSBs) in response to cellular stress (Aly et al, 2019; Jolly et al, 1999; Ninomiya et al, 
2020). Ribosomal intergenic noncoding RNA (rIGSRNA) can induce the formation of amyloid-
like solid structures termed amyloid bodies by interacting with the amyloid-converting motif 
(ACM) in targeting proteins (Audas et al, 2016).  
It has been reported that circRNAs can bind to some RBPs and modulated their function (Li et al, 
2017b). It has been proposed that circRNAs may interact, store, and sequester proteins to 
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specific subcellular locations and provide dynamic scaffolds for the assembly of proteins and 
modulate their functions (Du et al, 2017c). The sequence examination of candidate circRNAs 
using CircInteractome database showed multiple potential binding sites for RBPs that are 
reported to be included in RNP granules (Figure 4-1). For instance, AGO2 that have multiple 
binding sites on CDR1as (43), hsa_circVIM_005 (17), and hsa_circDNM1_004 (3) have been 
shown to present in RNP granules (Gallois-Montbrun et al, 2007; Goodier et al, 2007). FUS also 
have multiple potential binding sites on CDR1as (26), hsa_circVIM_005 (2), and 
hsa_circDNM1_004 (3) and is included in RNP granules (Qamar et al, 2018). The involvement 
of IGF2 mRNA-binding protein family (IGF2BPs) that have three members (IGF2BP1, 
IGF2BP2, and IGF2BP3) in RNP granule formation have been reported in several studies 
(Guzikowski et al, 2019; Vijayakumar, 2018; Wächter et al, 2013; Zeng et al, 2019). All the 
members of this protein family have multiple potential binding sites on CDR1as and 
hsa_circVIM_005. The other example of RBP that have multiple potential binding sites on 
hsa_circVIM_005 (6) and hsa_circDNM1_004 (2) is Polypyrimidine tract-binding protein (PTB 
also known as hnRNP1). PTB also contributes in RNP granule formation through interaction 
with RNAs (Guil et al, 2006; Li et al, 2012; Lin et al, 2015). Altogether the localization in RNP 
granules of circRNAs that have multiple potential binding sites for RBPs involved in RNP 
granule formation might indicate the potential role of these circRNAs in RNP granule biology.  
It has also been proposed that interactions between circRNAs and RBPs might not be only 
sequence-dependent but that they might also be driven by the tertiary structures of circRNAs (Du 
et al, 2017c). Moreover, their specific covalently closed structures result in a distinct tertiary 
conformation of circRNAs that is different from their linear counterparts (Jeck & Sharpless, 
2014).  It has been proposed that different tertiary structures for circRNAs in certain tissues, 
cells, and even different cellular environments might account for alterations in the preference for 
binding to specific RBPs. Therefore, these circRNAs can play different roles in different tissues, 
cell types, and cellular conditions through the interaction with different RBPs (Du et al, 2017a). 
It is possible that cellular stress might alter the tertiary structure of the candidate circRNAs 
whose colocalized with RNP granule markers and in doing so, augment their ability to interact 
with components of RNP granules. In addition, the circular nature of circRNAs without free ends 
makes them exceptionally stable, with the median half-life of at least 2.5 times longer than that 
of their linear RNA isoforms.  These properties make circRNAs attractive candidates as scaffolds 
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for the formation of RNP granules.  Thus, circRNAs can be considered as a potential candidate 
for nucleating RNP granules and providing a scaffold for their formation. 
4.4 Future direction 
In order to proof that designed primers for candidate circRNAs are detecting expected sequences, 
and also to characterize the multiple bands for circRNAs hsa_circDNM1_004 and 
hsa_circVIM_005 from the qPCR, first I need to optimize the qPCR using different annealing 
temperatures and concentrations of DMSO. After the optimization, if I still detect excessive 
bands for circRNAs, I need to clone those bands into a pGEMT-easy vector for further 
sequencing. I also need to design a new set of primers for hsa_circANXA1_001 as the other two 
sets of primers did not work properly. 
While I observed the colocalization of a selected group of candidate circRNAs with the markers 
of RNP granules under osmotic stress condition in HEK293T cells, additional experiments 
analyzing the effect of other kinds of cellular stress, such as oxidative and metabolic stresses will 
provide a more complete understanding of the mechanisms behind the observed colocalizations 
and whether such a response is a generic one independent of the nature of the cellular stress. The 
study of the stress-induced subcellular localization of candidate circRNAs in neuronal cell lines 
or ppatient-derived induced pluripotent stem cells (iPSCs) will provide more evidence of the 
potential role of circRNAs in ALS pathogenesis. As I have selected the candidate circRNAs 
from upregulated circRNAs in spinal cord tissue of ALS patients, the study of the expression and 
subcellular localization of candidate circRNAs in motor neurons of spinal cord tissues of ALS 
patients using the FISH technique will help to understand the potential function of candidate 
circRNA in ALS pathogenesis. 
A major future direction for this work is to determine whether candidate circRNAs contribute to 
RNP granule formation in response to stress. Does reduction or loss of CDR1as, 
hsa_circVIM_005, and hsa_circDNM1_004 result in reduced RNP granule formation under 
stress?  Does reduction or loss of CDR1as, hsa_circVIM_005, and hsa_circDNM1_004 result in 
reducing cell viability in response to stress?  Do CDR1as, hsa_circVIM_005, and 
hsa_circDNM1_004 interact with RBP components of RNP granules? The answer to these 
questions, it will be necessary to understand the participation of these circRNAs in RNP granule 
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formation. Therefore, further analyzing the candidate circRNAs in these studies and whether loss 
of these circRNAs via knockdown or knockout models could contribute to altered RNP granule 
formation upon stress will help us to understand their contribution to the pathogenesis of ALS. In 
addition, I need to acquire 3-D images of unstressed cells and quantify potential colocalization of 
candidate circRNAs with marker of RNP granules to get a better comparison of stress and 










Figure 4-1: RNA-binding protein sites matching to circRNAs. A) CDR1as. B) 
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